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ABSTRACT
The ATP-binding cassette (ABC) superfamily is pivotal to a number of important
biochemical processes and ubiquitous in all kingdoms of life. Previous studies
of ABC transporters have been heavily focused on the structural determination
of the different intermediates of the transport cycle. In order to characterize the
mechanism of an E. coli L-methionine transporter, which is an ABC importer,
we first collated previously reported structural information on the conformational
states of several well characterized ABC importers and associated binding proteins,
and identified four major conformations (i.e., pre-T, outward, post-T, and inward
state). We stabilized these intermediates using appropriate mutations, substrates,
and nucleotides. We then studied the kinetics and thermodynamics of the formation
of these states using surface plasmon resonance (BiaCore, GE Healthcare) and
MicroScale Thermophoresis (NanoTemper). We developed a quantitativemodel that
details the kinetic and molecular mechanism of E. coli MetNI. Towards this goal,
we extended the Two-State, alternating access model to include other intermediates
that are crucial to transport and are using this to provide a temporal understanding
of transport. While this model is developed to describe the behavior of the L-
methionine MetNI importer, it may also have predictive power for other ABC Type
I importers, since the NBD’s response for coupling transport to ATP-binding and
hydrolysis are highly conserved in this family.
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1C h a p t e r 1
INTRODUCTION
Membrane carriers are responsible for moving solutes across biological membranes
for purposes that are essential tomaintaining cellular homeostasis, including nutrient
intake and waste disposal. Their very existence arises from the nearly impermeable
nature—with the exception of very small, uncharged molecules like oxygen and
nitrogen—of biological membranes. All other transport requires that a membrane-
facilitator move substrates in and out of membranes. Passive transport takes ad-
vantage of the downhill electrochemical gradient, while active transport requires
the coupling of an energy source to enable the thermodynamically unfavorable re-
action. The ATP-binding cassette (ABC) transporters are active transporters that
couple substrate transport with obtaining energy stored in the high-energy phos-
phate bonds of adenosine triphosphate (ATP). To accommodate transport needs of
cells, many different transporters are encoded in the genomes of organisms. In E.
coli, about 10% of the genome encodes for transport purposes. One third of the
transporters are ABC transporters (Rees, Johnson, and Lewinson, 2009).
1.1 ABC Transporters
ABC transporters are one of the largest transporter families. They belong to a su-
perfamily of integral membrane proteins that power the movement of many different
types of solutes across the membrane through energy harvested from ATP binding
and hydrolysis.
ABC transporters function either as importers to bring in nutrients (Hollenstein,
Frei, and Locher, 2007), or exporters to move out lipids, toxins, and wastes. ABC
transporters are present in all kingdoms of life (Linton and Higgins, 1998). While
ABC exporters exist in both prokaryotes and eukaryotes, importers are only found
in prokaryotes (Linton and Higgins, 1998). There are about 50 ABC transporters
found in humans (Dean, Rzhetsky, and Allikmets, 2001; Moitra and Dean, 2011).
They are involved in the regulation of ions and solute concentration in many vital
biochemical processes, including multidrug resistance (Lage, 2003), cholesterol and
lipid transport, and homeostasis (Riordan, 2008; Aittoniemi et al., 2009; Bryan et
al., 2007). Malfunction of these proteins in eukaryotes is known to cause several
diseases, including cystic fibrosis, diabetes, and hypercholesterolemia (Dean and
2Annilo, 2005). These examples underline the necessity for a greater understanding
of the mechanistic behavior of ABC transporters.
The architecture of an ABC importer consists minimally of four domains: two
transmembrane domains (TMDs) that are located in the lipid bilayer, and two highly
conserved nucleotide binding domains (NBDs, or ABCs) with the two bound ATPs
sandwiched between the two Walker A motifs. ABCs can be further divided into
two subdomains: first, the catalytic core domain, which contains the conserved
P-loop or Walker A motif (GXXGXGK(S/T)), and a Walker B motif (xxxxD, x
= hydrophobic), a Q-loop and an H-loop (or switch region), and second, a more
structurally diverse alpha helical domain, which contains the ABC signature motif
LSGGQ. The catalytic core has a Walker A region that is critical for ATP binding
and a Walker B region that is essential for hydrolysis. The general structures of
ABC transporters can be demonstrated through two structures, BtuCDF (Korkhov,
Mireku, and Locher, 2012) and Sav1866 (R. J. Dawson and Locher, 2007). Addi-
tional domains that have regulatory functions can be fused to the TMDs or NBDs.
Examples include OpuA, MalK, and the cystic fibrosis transmembrane conductance
regulator (Rees, Johnson, and Lewinson, 2009; Kadaba et al., 2008; S. Chen et al.,
2013).
ABC importers only exist in prokaryotes, therefore, ABC importers are structurally
unique to microbes. They represent a unique appeal, such as studying peptidoglycan
biosynthesis for the rational design of antibacterial agents. Multiple drug resistance
(MDR) transporters are a type of ABC transporter (Lage, 2003). Multidrug re-
sistance is a major challenge in cancer and infectious diseases. Such resistance
interferes with treatments and leads to longer recovery times and higher mortality
rates (Dean, Rzhetsky, and Allikmets, 2001).
Experiments targeting the structures of ABC transporters during these conforma-
tional changes have further illuminated the transport process, particularly the role
of NBDs. The NBD consists of a highly conserved catalytic core (Higgins, Hiles,
et al., 1986) and a more structurally diverse alpha-helix domain (Schmitt et al.,
2003). The spatial location of these two domains is used to classify the state of
the NBDs. They have been observed in multiple conformations: open, semi-open,
and closed (Kadaba et al., 2008; Oldham and J. Chen, 2011a; Oldham and J. Chen,
2011b). The closed NBD state is when the two domains are packed closely next to
each other sandwiching ATP. In contrast, open NBDs occur when the two NBDs
move away from the central axis of the transporter. Semi-open NBDs correspond
3to the state intermediate between open and closed. The closing of NBDs is believed
to be driven by the binding of ATP, while the opening of the NBDs is stimulated by
hydrolysis (Moody et al., 2002). The opening and closing of NBDs are connected
to multiple events, such as ATP binding and hydrolysis, binding protein association
and dissociation, hydrolysis products dissociation, and others (Oldham and J. Chen,
2011a).
The proper function of most ABC importers relies on a periplasmic binding protein
to capture substrate and initiate transport. These proteins were first discovered
when cells were subjected to osmotic shock and binding proteins were released to
the solution (Heppel, 1969), suggesting that they are soluble proteins, which indeed
they are. When substrate diffuses to the periplasm, the binding protein binds to
it with high enough affinity to sequester substrate, which may be present in low
concentration.
The Alternating Access Model
How does a membrane facilitator move a molecule from one side of the membrane
to another? An important concept in the ABC transporter mechanistic analysis was
introduced in the 1960s, and it has had a strong influence on the field (Jardetzky,
1966), the alternating access model. According to this model, membrane carriers
have two major conformations, one opens up towards the periplasm, the other the
cytoplasm. They are called the outward-facing and inward-facing conformation,
respectively. Several ABC transporter systems have demonstrated to follow this
framework. Since the alternating access model is an oversimplification of the
transport mechanism, we aim to elucidate a detailed mechanism that explains how
conformational changes couple with substrate translocation and ATP hydrolysis to
complete the reaction.
1.2 A Methionine ABC Transporter, MetNI
MetNI belongs to the ABC transporter superfamily. It was discovered in the 1970s
through a set of elegant in vivo experiments (Kadner, 1974). Kadner also identified
methionine derivatives, such as D-methionine, that are substrates of MetNI (Kad-
ner, 1977). Importantly, he established that under high intracellular L-methionine
concentration, transport is inhibited. This feedback mechanism is known as “trans-
inhibition” (Kadner, 1975) and appears to be unique to MetNI.
When a structure of the inward-facing conformation of MetNI was determined
(Kadaba et al., 2008), themolecular architecturewas available for close examination.
4MetNI is an integral membrane protein that consists of two TMDs and two NBDs;
each NBD divides into two subdomains, the nucleotide binding site and the C-
terminal (C2) regulatory domain. The mechanism of trans-inhibition that Kadner
observed was not well understood previous to this paper; the observation that the
intracellular L-methionine concentration modulates the rate of transport through a
negative feedback loop helped to clarify this. In this 2008 paper, when the MetNI
crystal was soaked with selenomethionine, the electron density shows evidence that
methionine binds to the C2 domain. This suggests that trans-inhibition is mediated
by the C2 domain. It is hypothesized that when the imported substrate builds up in
the cytoplasm, L-methionine binds to the C2 domain and results in the inhibition
of hydrolysis and transport (Kadner, 1974; Kadner, 1975; Kadner, 1977). Kinetic
assays show that L-methionine inhibits hydrolysis non-competitively (Yang and
Rees, 2015).
The MetNI system has a 30 kDa binding protein, MetQ. It co-purifies with substrate
L-methionine. This indicates the high affinity binding of the substrate to MetQ.
This notion was later confirmed with affinity measurement by an SPR assay; it
was determined to be around 10 nm. The liganded MetQ has been captured in X-
ray crystallography (Nguyen et al., 2015). The observed bond/salt bridge network
between protein side chains and the methionine -amino and carboxyl groups is
thought to contribute to the high affinity of the ligand binding to MetQ (Nguyen
et al., 2015). MetQ consists of two domains: the N- and C-domain. While each lobe
has a conserved topology, variations in the connections between the lobes can be
used to classify periplasmic binding proteins into distinct clusters (Berntsson et al.,
2010). The opening and closing of these two lobes created twomajor conformations:
open and closed (Mao et al., 1982). Unlike the maltose transporter system, MetQ
does not seem to partake in the regulation of transport.
1.3 The Overarching Questions
There are many interesting questions concerning the transport mechanism that
MetNI employs to efficiently uptake L-methionine. To elucidate this mechanism, we
would like to address: (1) How do the rate and affinity constants help to understand
the transport mechanism? (2) What are the advantages of having a binding protein?
(3) What is the transport mechanism for MetNI? (4) Is this mechanism universal for
all ABC transporters? To address these questions, we first set up a kinetic framework
and evaluate information given by each model, starting from a simple system.
51.4 Transporter Kinetics
Developing a kinetic mechanism that can accurately account for the behavior of
transport proteins is a good way to encapsulate what we learn about membrane
carriers and apply the knowledge of one system to another. To approach this, a
simplified model is examined to get familiar with the logistics of a transport process
under general conditions.
A General Simple Kinetic Transport Model, M1
We start with a model (Dill and Bromberg, 2003) that assumes there are only four
states of the carrier during transport. Membrane transport follow four steps: (1) the
carrier binds the solute on one side of the membrane; (2) the carrier hauls the solute
across; (3) the carrier unloads the solute on the opposite side of the membrane; (4)
the carrier resets itself. The goal is to calculate the rate of solute being carried across
the membrane based on the energetic difference between the two spaces separated
by an impermeable surface. We describe transport going from left to right, but the
kinetic mechanism applies to the opposite direction as well.
This model should extend to include the coupling of an energy source. Carriers that
are involved in gradient driven transport are called channels, while those involved
in active transport are called pumps and transporters. The M1 model is a general
description of all carriers, each type of transport is a special case of this model.
The rate of solute across the membrane can be calculated as:
Vtransport = kr[ESl] − kl[ESr] (1.1)
The total concentration of enzyme is conserved:
[Etot] = [ESl] + [El] + [ESr] + [Er] (1.2)
At steady state, the rate of solute transport must be equal to the rate of the carrier
resetting itself:
Vtransport = Vreset (1.3)
The association constants Kl and Kr are defined as follows:
6Figure 1.1: A model of carrier proteins transporting solute across membranes
(Dill and Bromberg, 2003). The scheme starts from the left side of the membrane
where the carrier, El, binds to solute, cl, and forms an enzyme-substrate complex,
ESl. This complex changes its conformation to ESr, which exposes the solute to the
right side of the membrane. Then ESr dissociates and yields Er and cr on the right
side of the membrane. Finally, the carrier resets itself from Er to El. This model
describes a general transport mechanism. Active Transport, which is a special case
of this model, extends from the basic scheme.
on the left side:
Kl =
[ESl]
[El][cl] (1.4)
on the right side:
Kr =
[ESr]
[Er][cr] (1.5)
Combining Equations 1.2 and 1.3, we have:
[ESl] = [Etot]( klkr + kl )(
Kl[cl]
Kl[cl] + 1 ) (1.6)
Since the system is symmetric, [ESr] is:
[ESr] = [Etot] krkr + kl (
Kr[cr]
Kr[cr] + 1 ) (1.7)
Solving for Vtransport yields:
Vtransport = kr[ESl] − kl[ESr] = [Etot]( klkrkr + kl )(
Kl[cl]
Kl[cl] + 1 −
Kr[cr]
Kr[cr] + 1 ) (1.8)
The maximum rate of transport occurs when ( Kl[cl]Kl[cl]+1 −
Kr [cr]
Kr [cr]+1 ) equals to 1. There-
fore, Vmax can be expressed as:
7Vmax = [Etot]( kr klkr + kl ) (1.9)
Vtransport can be expressed in terms of Vmax:
Vtransport = Vmax( Kl[cl]Kl[cl] + 1 −
Kr[cr]
Kr[cr] + 1 ) (1.10)
Passive Transport, a special case of the model
During passive transport, solute moves from the side of the membrane with higher
solute concentration to the other side. In the simplest passive transport case, the
affinity for solute on the left is the same as the right. Therefore, we define a general
K:
K = Kl = Kr (1.11)
Let’s say the solute is passively moving from the left to the right; then we have
[cl] > [cr] (1.12)
For passive transport, when the solute concentration is very low, we have
K[cl]  1 (1.13)
and
K[cr]  1 (1.14)
Under these specific conditions of passive transport, Equation 1.10 can be reduced
to the below:
Vtransport = VmaxK([cl] − [cr]) (1.15)
That means when the concentration of solute is small and when the affinity of
the carrier protein that binds to the substrate from either side of the membrane is
equal, the rate of passive transport is linearly proportional to the difference of the
concentration on both side, which is the concentration gradient across themembrane.
However, when the concentration of solute is sufficiently high, the flux first rapidly
decreases, then the decrease slows down to plateau, then the transport reverses
directions, as indicated by a negative flux following Equation 1.10 (Figure. 1.2).
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Figure 1.2: Passive transport when the solute concentration is high. The
rate of solute transported across the membrane is plotted against the ratio of the
concentrations of the solute on the right side of the membrane over the left. The
equation used for graphing this is Equation 1.15
A Three State Kinetic Model with a Binding Protein, M2
We include additional components for the transporter, a binding protein, Q, and
an energy source, ATP (Figure 1.3), to better understand the kinetic mechanism of
active transport by ABC importers. Prokaryotic importers depend on high affinity
periplasmic binding proteins to transport.
Figure 1.3: ATP-powered transporter in a binding protein dependent system
This model starts with a transporter bound to ATP (i.e. ’ET’), which binds to
substrate (i.e. ’met’) and ’Q’ to form the enzyme-substrate complex ’ETmetQ’. This
complex subsequently hydrolyzes ATP, dissociates ’Q’, and delivers methionine to
yield ED. To reset the cycle, the ADP in ’ED’ is replaced by ATP to form ’ET’.
9The steady state rate equation can be derived as follows:
Mass conservation:
[Etot] = [ET] + [ETmetQ] + [ED] (1.16)
In steady state, the rate of formation of [ETmetQ] equals the rate of consumption of
[ETmetQ]
k1[ET][Q] = (k−1 + k2)[ETmetQ] (1.17)
In steady state, the rate of substrate transport must be equal to the rate of the transport
resetting itself,
k2[ETmetQ] = k3[ED] − k−3[ET] (1.18)
We assume that the ligand binding is at equilibrium where k−1 >> other rates, and
k1 [Q] >> other rates, and the dissociation constant K is defined as:
K =
k−1
k1
(1.19)
The rate of transport is,
Vtransport =
d[met]
dt
= k2[ETmetQ] =
k2k3
k2+k3
[Q][Etot]
(k−3+k3)(k−1+k2)
(k2+k3)k1 + [Q]
≈
k2k3
k2+k3
[Q][Etot]
k−3+k3
k2+K3
K + [Q]
(1.20)
The rate of hydrolysis is,
d[Pi]
dt
= k2[ETmetQ] + k−3[Etot] = k−3k3(k−1 + k2) + k2k3k1[Q](k−3 + k3)(k−1 + k2) + (k2 + k3)k1[Q] [Etot]
(1.21)
which simplifies to:
d[Pi]
dt
=
k−3k3
(k2+k3)K +
k2k3
(k2+k3) [Q]
(k−3+k3)
(k2+k3) K + [Q]
[Etot] (1.22)
When the ATPase rate is rate-limiting: k2, k−3  other rates
d[met]
dt
=
k2[Q][Etot]
K + [Q] (1.23)
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d[Pi]
dt
=
k−3K + k2[Q]
K + [Q] [Etot] (1.24)
1.5 Introduction to MST and SPR
Herewe discuss two commonly used instruments, SPR andMST to study the kinetics
and thermodynamics of the different conformations of MetNI during the transport
cycle.
Surface Plasmon Resonance (SPR)
From protein biochemistry to environmental safety, molecular binding processes
underpin some of the richest avenues of research in a wide array of fields. Although
there are a number of other techniques used to study these processes (e.g., ITC and
ELISA), surface plasmon resonance (SPR) is an increasingly popular method picked
to determine rates and affinities of various interactions between binding molecules,
protein-protein and protein-small-molecule in our studies. The application of SPR
results in a highly-sensitive technique used for real-time, binding-event monitoring.
SPR is valued for its minimal sample consumption, label-free detection ability,
higher quality kinetics (i.e., association and dissociation constants, in addition to
equilibrium), and faster experiments.
Surface plasmon resonance is a physical, optical phenomenon that can be utilized
to observe and record refractive index changes. In the Biacore SPR instrument,
analysis of these differences in refractive indexes over time allows for binding,
kinetics, affinity, specificity, and concentration studies in a single device. This utility,
combined with high sensitivity and high reliability relative to other comparable
techniques, made SPR ideal for our studies.
In order to better understand how the SPR technique works, we must first discuss a
few concepts. Key to SPR are the free conduction electrons inmetals. In interactions
between the metal and a driving electric field, these electrons have out-of-phase
oscillations with respect to the electric field, which at optical frequencies, give most
metals a couple of notable properties. First is a negative dielectric constant, which
results in the physical property of having very high reflectivity. Second, and most
importantly, there can be charge density oscillations, both volume and surface, in
the free electron gas of the metal. Some of these charge density oscillations can be
11
caused by light.
As we know, light is an electromagnetic wave that has both electric and magnetic
fields. These fields oscillate perpendicularly to one another and generally run
normal to the direction of motion. When visible light is directed at a conductive
metal, the electric field of the light causes free conduction electrons at the surface of
the metal to begin vibrating. However, under certain conditions discussed below, a
longitudinal wave of electrons can become excited by the light wave, which results
in its own electromagnetic wave. This electron density wave, and associated electric
and magnetic fields, is called a "surface plasmon" and is confined to the interface
between two media with differing refractive indexes. It may be easier to think
of a surface plasmon as light "bound" to the surface of a conductive metal and
propagating along the surface while presenting as an electromagnetic field.
One particular property of surface plasmons is important to our discussion of SPR:
it has a shorter wavelength when compared to light of the same frequency. Since
energy is proportional to momentum, we can also say that photons have less momen-
tum than surface plasmons of the same frequency. Therefore, in order to convert a
photon into a surface plasmon, additional momentum must be provided according
to the conservation of energy and momentum. This conversion of photons into
surface plasmons occurs inside the Biacore SPR instrument using the Kretschmann
configuration.
The Kretschmann configuration takes a thin metal film (e.g. gold) and places
it between two dielectric materials with differing refractive indexes. In the Bia-
core instrument, a prism is used as the higher refractive index material, while an
experiment-specific solution serves as the lower refractive index medium. Plane-
polarized light is shone through the prism during SPR. When light travels from
a higher refractive index material to one of lower refractive index, a phenomenon
known as total internal reflection (TIR) can occur.
When light is directed from the denser (i.e. higher refractive index) material at
angles of incidence less than the so-called "critical angle", both refraction into
the less dense (i.e. lower refractive index) material and reflection into the denser
material occur. As the incidence angle increases, the angle of refraction increases
non-linearly at a faster rate and the light that is refracted becomes dimmer (i.e.
less refraction), while the reflected light becomes brighter (i.e. more reflection).
Once the angle of refraction is equal to or greater than 90°, no light refraction is
observable, and all the light is reflected back to the denser medium. The incidence
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angle that produces an angle of refraction equal to 90° is the critical angle. Any
light shone at an incidence angle greater than the critical angle undergoes TIR. To
summarize, there are two requirements for TIR: light must originate from the denser
medium and approach the less dense medium, and the angle of incidence must be
greater than the critical angle.
Under TIR, reflected photons create an electrical field at the interface between the
two media. No energy is actually transmitted across the interface, but the electrical
field extends beyond the boundary of the denser medium and into the metal film
and the less dense medium. The electrical field component that is normal to the
interface is called an evanescent wave. Evanescent waves have amplitude that
decrease exponentially with distance from the interface and generally fully decay
over one light wavelength. These evanescent waves are critically important to SPR
as they serve as the source of excitation for surface plasmons.
The excitation of surface plasmons is also called surface plasmon resonance. In order
for SPR to occur, the momentum of the surface plasmonsmust match themomentum
of incident light, also called momentum resonance. Under the right conditions for
wavelength, angle of illumination, and refractive index of the media, photons are
absorbed and become surface plasmons, which is observable as a "shadow" in the
reflected light. This serves as the major mechanism by which the SPR technique
functions.
In the Biacore instrument, plane-polarized light is focused into a wedge-shaped
beam. This beam is aimed at the "TIR interface", which consists of the prism (i.e.
the high refractive index medium) and the sensor chip; the sensor chip contains the
gold film and multiple microfluidic channels. The low refractive index medium is
the surface coating of the sensor chip and the injected sample solution. The angle
of "minimum reflectance intensity", which is the illumination angle that exhibits
SPR at the TIR interface, is recorded as a baseline. As various interactions occur on
the surface of the sensor chip, solute concentration changes. These changes affect
the refractive index of the "low refractive index" medium, which in turn affects
the penetration ability of the evanescent waves produced by TIR. A change in the
evanescent waves necessitates a change in the angle of incidence of the light in order
to exhibit SPR. This difference in angle of incidence is measured as the response
signal. Useful depth of detection is about 300 nm. This limits the instrument to
only detect close intermolecular interactions.
In summary, SPR can occur when plane-polarized light hits an electrically con-
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ducting surface, generally a thin, metal film, at the boundary between two media
with different refractive indexes. Under TIR, electrons from the outer shell or
conduction-band of the metal film absorb photons from the polarized light to form
"surface plasmons". Evanescent waves from totally internally reflected photons
causes excitation of these surface plasmons, which results in SPR. SPR is observ-
able as a "shadow" in the reflected light. These SPR shadows are used in the Biacore
SPR instrument to generate a response signal that is influenced by biomolecular in-
teractions on the sensor chip surface.
Assay Setup
Tomake an SPRmeasurement, it requires a molecule to be immobilized on a sensor-
chip. The counterpart binding partner flows through the microfluidic channel. They
are called ligand and analyte, respectively.
First, the molecular weights of the two molecules need to be considered. The
relationship between the response signal and the mass of the ligand and analyte
is defined in Equation 1.25. The mass ratio of analyte to ligand should be within
the same order of magnitude. Also, it is ideal for the analyte to be larger than the
ligand to obtain a robust response. Therefore, SPR is not an appropriate technique
to analyze binding interactions that involve a small molecule (e.g. ions) and a
macromolecule (i.e. protein).
Response(RU) = immobilization(RU) × analyte(MW)
ligand(MW)
(1.25)
The method of immobilization can be through covalent binding or ionic interaction.
To immobilize the ligand, the molecules can be added to the sensor surface to bind to
high affinity pre-attachedmolecules, for instance, antibodies, Ni-NTA.Alternatively,
molecules can be concentrated to the surface using buffer with a pH lower than the
isoelectric point of the protein to form covalent bonds between the protein and the
carboxymethylated dextran on the chip.
A sensorgram records the binding interaction over time. A sensorgram consists of
three parts, association, equilibrium, and dissociation. The binding curves can be
fitted according to a model that describes the reaction measured. Methods of data
fitting and evaluation of the fit are discussed in Section 3.4 and 3.5.
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Microscale Thermophoresis (MST)
Thermophoresis is an intrinsic property of a molecule where a directed movement
occurs in a temperature gradient, dependent on the size, charge, and hydration shell
of the molecule. These factors are encapsulated in the Soret Factor, ST (Duhr and
Braun, 2006b; Duhr and Braun, 2006a) ). The change in hydration shell can be
a result of changes in their primary, secondary, tertiary, and quaternary structures.
This behavior of molecules is a deviation from the random distribution of molecules
by Brownian motion in equilibrium at a constant temperature.
The directed movement is different when a molecule is bound to another molecule.
Therefore, the phenomenon can be used to measure inter-molecular interactions. It
is suitable for macro-molecules binding because binding of these large molecules
usually causes a change in one or all three of the factors mentioned above. The
upper mass limit for macromolecules can be as large as a bacterium. It can also be
used to measure an interaction between a macromolecule and a small molecule (e.g.
ions and amino acids) because even though the binding of a small molecule might
not induce a measurable change in size, it can, however, induce changes in charge
and the hydration shell.
The tracking of the directed movement is done by fluorescent labeling of one of
the two binding partners. At the start of the measurement, the fluorescently labeled
molecules are evenly distributed among the non-labeled molecules at equilibrium.
Therefore, this is a steady state measurement. Before a higher temperature is
introduced, the binding event has already occurred. Then a small spot within this
solution is heated; there is a hot spot within the cooler solution. Simultaneous to
heating up a spot, the amount of fluorescence gain (if molecules move towards the
hot spot) or lost (if the molecules move away from the spot) on the spot is recorded.
The direction that the molecules move is an intrinsic property of that molecule.
The relationship between the change of concentration of the fluorescently labeled
molecules in a temperature gradient and the Soret factor is expressed as:
chot
ccold
= exp(−ST∆T) (1.26)
The MicroScale Thermophoresis Instruments (MST) are manufactured by Nano
Temper Inc, a German company. They offer a variety of MST instruments to
accommodate inter-molecular interactions that have different binding affinities. The
instrument used for the experiments in this thesis is called NT.115. One of the
most prominent features of this instrument is the sample solution that is loaded to
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a capillary with a width of 10mm. The length of the capillary does not matter
because the cross section of the capillary is heated. Therefore, the volume of the
heated spot can be calculated as 10mm multiplied by the cross section area of the
infrared laser, which is small. Therefore, MST consumes a small amount of sample.
Each measurement is as long as a fluorescence scan; it takes about 40 seconds of
measurement time per titration point.
There are caveats to using MST. MST is an equilibrium measurement that detects
a wide range of affinities. It is quick to perform, and thus can be a good starter
instrument. However, the readout of MST depends on the Soret factor change from
being a lone molecule to be bound to another molecule. The change in Soret factor
depends on the size, charge, or hydration shell change upon binding. A binding
event can occur but not induce a measurable change in any of the above-mentioned
factors, which results in directed movement that is too small to be detected by
the fluorescence scanner. Therefore, a limitation of MST is that if such change
is too small to create a thermophoresis profile change detectable by the specified
fluorescence detector, false negatives can result.
Assay Setup
An MST measurement requires labeling of one of the two partners for the binding
interaction. There are two types of commonly used protein labeling strategies:
primary amines and maleimide chemistry. Since lysine is abundant in proteins,
labeling is often non-specific. It has been shown that non-specific label serves well
to record fluorescence change of the heated spot over time. On the other hand, with
proteins containing a single or no cysteine, specific labeling can be achieved in some
cases.
Data is plotted on a semi-log scale with the y-axis as the binding signal and the
x-axis as the concentration of the titrant. The binding curve is either fitted using
the Kd equation (Equation 1.27) or the Hill equation (Equation 1.28) to output a
dissociation constant and a hill coefficient if applicable.
Fit function for Kd from the law of mass action:
A + T ↔ AT (1.27)
[A0]: The concentration of the fluorescently labeled molecules
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[T0]: The concentration of the titrated molecule T
[AT]: The concentration of the complex formed by A and T
FractionBound =
1
2[A0] ([T0] + [A0] + Kd −
√
([T0] + [A0] + Kd)2 − 4[T0][A0]
(1.28)
Fit using the Hill equation.
A + nT ↔ ATn (1.29)
EC50 is the concentration of molecule T when half of A is bound to T.
n: Hill coefficient
FractionBound =
1
1 + (EC50[T0] )n
(1.30)
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C h a p t e r 2
TRANSPORT MECHANISMS FOR ABC IMPORTERS
2.1 Introduction
Previous studies of ABC transporters have been heavily focused on the structural
determination of the different intermediates of the transport cycle. In this chapter,
we place an emphasis on how the conformational changes, from one intermediate
to another, drive the transport process and complete the transport reaction. We also
analyze how the conformational changes enable the coupling of ATP hydrolysis and
substrate translocation.
Prior to discussing the conformational changes of ABC importers, it is important
to note that there are two types of importers: Type I and Type II. The subject
of my study, MetNI, along with the other well characterized importers MalFGK2,
ModBC, and histidine are all Type I transporters. The two most prominent Type II
importers are BtuCD and MolBC. These two types were previously classified based
on topology and architecture (Goetz, Perozo, and Locher, 2009; Joseph et al., 2011).
However, more recently, the field has transitioned to including transport mechanism
as a criterion during classification (Locher, 2016). This shift in criterion priority is
underpinned by multiple findings. First, transport mechanisms can be identified by
the number and type of folds of the transmembrane helices (Vigonsky, Ovcharenko,
and Lewinson, 2013). Second, and most importantly, it has been unequivocally
demonstrated that Type II importers have distinct conformations, relative to Type I
importers, during transport (Lewinson et al., 2010; Locher, 2016). Therefore, since
the transport mechanism serves such a vital role in ABC-importer classification, our
interest is to elucidate the MetNI Type I transport-cycle.
In this chapter, we develop a framework for the mechanistic analysis of ABC trans-
porters. First, we collate previously reported structural information on the con-
formational states of ABC importers and associated binding proteins. Then, we
summarize the available kinetic and thermodynamic characterization of the trans-
port intermediates. From these considerations, we propose the followingmechanism
that describes the transport cycle for ABC Type I importers.
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Figure 2.1: Ageneral transportmechanismproposed forType IABC importers.
There are five major enzyme-states during substrate transport, with three states
being complexes with a binding protein. The model assumes that the transporter
binds to ATP readily to form ’ET’. Transport is initiated when a liganded binding-
protein comes in contact with ’ET’ to form a protein complex, ’ETBS’, which
is the pre-translocation conformation. The Substrate moves from ’B’ (binding
protein) towards ’E’ (Enzyme, transporter) to form ’ETSB’, which is the outward-
facing conformation. After the substrate is translocated to the cytoplasm, ATP is
hydrolyzed yielding the post-translocation state, which is bound with ADP and Pi.
ATP replaces ADP in the transporter and a new transport cycle can start.
2.2 Binding Protein Conformations
Substrate translocation by ABC importers is dependent on periplasmic binding
proteins that have a high affinity for substrate. The binding protein binds to substrate
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that enters into the periplasmic space and carries it to the membrane to interact with
the appropriate transporter. Here, we discuss four important points related to binding
proteins relevant to understanding the ABC import mechanism: 1) the reasons why
they are essential for transport; 2) their structural architecture; 3) X-ray structures
of the binding proteins for the most well-characterized Type I and Type II ABC
transporters; and 4) binding proteins can form a complex with the transporter in two
different conformations.
Prokaryotic ABC importers are dependent on binding proteins; we discuss the rea-
sons why they are essential. First, when the concentration of nutrients and ions that
enter into the periplasm is low, a high-affinity binding protein sequesters the sub-
strate for transport. Biochemical studies show that the affinity of the binding protein
substrate site is high, in the pm - nm range. Binding proteins are also important due
to their ability to stimulate ATPase activity of the transporter, as shown originally in
histidine permease studies (C. E. Liu et al., 1999). Therefore, periplasmic binding
proteins are essential for substrate translocation not only because of their affinity to
sequester substrate for transport but also their ability to stimulate ATPase activity.
Structurally, the binding proteins of ABC transporters consist of two domains (or
lobes), the N- and C-domains (Berntsson et al., 2010). There is a cleft formed by
a flexible hinge that connects the two domains (Spurlino, G. Y. Lu, and Quiocho,
1991). The opening and closing of these two lobes create two major conformations
(Sharff et al., 1992; Quiocho, 1990). The conformational change from the open to
the closed state is facilitated by the binding of the substrate to the binding protein.
Once substrate binds to the open state of a binding protein, the two domains of the
binding protein come in close contact with each other to form a substrate binding
site that occludes the substrate. The binding protein can form a complex with the
transporter in both its open or closed state.
There are structures of many binding proteins available. Here we describe the bind-
ing protein of the most well-characterized ABC importers (Table 2.1) (Hollenstein,
Frei, and Locher, 2007; Nguyen et al., 2015; Higgins and Ames, 1981; Oldham,
S. Chen, and J. Chen, 2013; Kim et al., 2013; Gouridis et al., 2015). For example,
the structural determination of the methionine binding protein MetQ occurred with
L-methionine bound (Nguyen et al., 2015). The maltose binding protein MalE has
been structurally determined in complex with the maltose transporter both in apo-
(Oldham, Khare, et al., 2007; Oldham and J. Chen, 2011b) and bound-state (Oldham
and J. Chen, 2011a). As discussed later, though the Type II importers operate using
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a fundamentally different mechanism, the structures and functions of the binding
proteins are comparable. For example, the structure of an open BtuF was found to
be in a complex with a post-T transporter (Hvorup et al., 2007; Korkhov, Mireku,
and Locher, 2012).
2.3 The Conformational States of ABC Importers
Type I ABC Importers
For our discussion, we begin by defining four conformational-states based on crys-
tallographic analysis: the pre-translocation (pre-T), outward-facing (outward), post-
translocation (post-T), and inward-facing (inward) conformation. Three of these
conformations—pre-T, outward, and post-T—are transporter-complexes that have
formed a complex with the binding protein. The pre-T conformation is bound to a
liganded binding protein, while the outward and post-T conformation are bound to
an apo binding protein. The pre-T and outward conformation are ATP-bound, while
the post-T conformation is ADP- and Pi-bound. The inward state is nucleotide-free.
The study of ABC transporters has been guided by the alternating access model,
which stipulates that to translocate substrate, the transporter opens towards one side
of the membrane to load the substrate, then switches the opening to the other side
of the membrane to unload. Specifically, the opening of the transporter is done
through the opening of the TMDs towards either side of the membrane. Therefore,
it is crucial to define the conformations of the TMDs. The substrate binding site
formed by the TMDs is called the translocation pathway substrate binding site
(’translocation pathway site’). The alternating access model stipulates that there are
twomajor conformations of the cavity formed by these twoTMDs and the orientation
of the opening in relation to the membrane (Jardetzky, 1966). The outward-facing
orientation of the TMDs forms a cavity which opens to the periplasm, while inward-
facing TMDs have the cavity open toward the cytoplasm.
The translocation pathway site has been observed in the maltose system (Oldham,
Khare, et al., 2007; Oldham and J. Chen, 2011b; Oldham and J. Chen, 2011a;
Oldham, S. Chen, and J. Chen, 2013) and an amino acid ABC importer Art(QN)2
(Yu et al., 2015). The maltose translocation sites were characterized to have a
Kd of 2mm from a MBP-independent MalFGK2 mutant study where this mutant
has its specificity for maltose unchanged (Cui, Qasim, and Davidson, 2010). This
observation showed that this site has a low affinity compared to the binding protein
substrate site. The low affinity of this site again emphasizes the importance of a
21
high-affinity periplasmic binding protein to assist transport.
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The Pre-translocation Conformation
The key features of the pre-T state are (as seen in Table 2.1): a closed, liganded
binding protein that is bound to the transporter; the TMDs of the transporter are
inward-facing; and the NBDs are semi-open (Oldham and J. Chen, 2011a; Hollen-
stein, Frei, and Locher, 2007). Even though the pre-T state has been observed to
be nucleotide-free in crystal structures, SPR studies of the MetNI shows that the
binding protein does not form a complex with the transporter in the absence of
ATP, therefore, without ATP bound to the NBDs, the pre-T conformation cannot be
established. We hypothesized that the pre-T state either has one or both ATP bound
to the NBDs. We will describe evidence for these features and their mechanistic
importance.
A closed, liganded binding protein bound to the transporter is supported by pre-
T crystal structures of the maltose transporter (Oldham and J. Chen, 2011a) and
ModB2C2 transporter (Hollenstein, Frei, and Locher, 2007). The binding protein
hands over the substrate to the transporter, which initiates a series of events that
facilitate transport and hydrolysis. These features of the binding protein have
two putative importance to the transport mechanism. First, the binding protein is
predicted to stimulate ATP hydrolysis. Second, the bound substrate is predicted
to stimulate the release of Pi (Bao, Dalal, et al., 2015). Therefore, the pre-T
conformation has set the stage for ATP hydrolysis.
Studies show that the TMDs are inward-facing (Oldham and J. Chen, 2011a). It is
hypothesized that the liganded substrate triggers the conformational change of the
TMDs from inward to outward-facing—a key feature of the outward state, which
follows the pre-T state. Therefore, the interaction of the liganded binding protein
with the inward-facing TMD is an important step in promoting the continuation of
the transport cycle.
The semi-open NBDs signal that this state is not yet poised for hydrolysis to occur.
In the ModB2C2 system, the structure of an intermediate state showed semi-open
NBDs (Hollenstein, Frei, and Locher, 2007). The closing of the NBDs will promote
the transporter to proceed to the outward state. Though there is controversy over
what molecular events precipitate the closing of the NBDs (Orelle, Ayvaz, et al.,
2008; Bao and Duong, 2013), generally, we believe that binding of both ATP to the
NBDs is the trigger. It is hypothesized that the closure of NBDs is concomitant to
the change of inward-facing TMDs to outward-facing.
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Some observations complicate the features of the pre-T state. For instance, the
translocation pathway site is supposed to be vacant in the pre-T state because the
substrate is still bound to the binding protein. However, the pre-translocation
conformation of MalFGK2 has a second maltose molecule in the translocation
pathway site (Oldham and J. Chen, 2011a). Even though this maltose is not likely to
be present in this conformation—presumably, an artifact of the high concentration
of maltose used during crystal preparation—this structure does show the presence
and the location of a TMD substrate binding site.
The Outward-facing Conformation
The key features of the outward conformation are: an open, unliganded binding
protein is bound to the transporter; the two TMDs are outward-facing and the
substrate is occluded in the cavity formed by the TMDs; the two NBDs are closed
and ATP-bound. Below we discuss the evidence and mechanistic importance of
these features.
An open, unliganded binding protein bound to the transporter is supported by studies
where MalE is in the open conformation during the catalytic transition state for ATP
hydrolysis via EPR (Austermuhle et al., 2004; J. Chen et al., 2001). When the
transporter is bound to an open binding protein (Oldham, Khare, et al., 2007; Khare
et al., 2009; Oldham and J. Chen, 2011b), it indicates that the substrate has already
dissociated from the binding protein and is bound to the translocation pathway site
of the transporter complex. The observation that the liganded binding protein in
the pre-T state possibly indicates that when a liganded binding protein binds, the
bound substrate interacts with the transporter and triggers a conformational change
to close the semi-open NBDs.
This unliganded binding protein is shown to form a complex with ATP-boundMetNI
with high affinity. For example, MalFGK2 forms a complex with the closed MalE
with an affinity of greater than 45 µm, while it is 60 nm with the open unliganded
MalE (Table. 2.2) (Bao and Duong, 2012; Bao and Duong, 2013). This observation
is also true for the MetNI system (in Chapter 3). The different affinities imply that
the outward state has a higher affinity than the pre-T state, if both states can be ex-
perimentally trapped. The hypothesized molecular significance of the outward state
having a higher affinity is the creation of a stable condition/platform for substrate
translocation and ATP hydrolysis to occur and to favor transfer of ligand from the
binding protein to the transporter.
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The TMDs are outward-facing, and the substrate is occluded in the cavity (Oldham,
Khare, et al., 2007). It is believed that the closure of the NBDs is concomitant
with the substrate dissociating from the binding protein and binds to the translo-
cation pathway site in the transporter (Oldham, Khare, et al., 2007). Therefore,
the three molecular events—the closure of NBDs, the conformational change of
TMDs from outward to inward-facing, and the substrate binding to the translocation
pathway site—are essential for proceeding to the post-T state to achieve substrate
translocation.
A prominent feature of this state is that the transporter has closed, ATP-bound
NBDs that are ready for hydrolysis. The closing of the NBDs necessitates the
conformational change from the pre-T to the outward state. However, there is no
consensus on the conditions for closure. Davidson et al determined that both MalE
and ATP binding are required for NBD closure using EPR (Orelle, Ayvaz, et al.,
2008). Conflictingly, Bao and Duong showed that ATP alone triggers the outward
state of the maltose ABC transporter and that the binding of MalE is not required
(Bao and Duong, 2013). Nonetheless, it is agreed that when the two NBDs have
moved closer to each other, the transporter is in its outward state.
Open-state Closed-state
MalFGK2E 60 nm > 45 µm
MetNIQ 25 nm 1100 nm
Table 2.2: Both MetNI and MalFGK2 forms a complex with a higher affinity with
their respective binding protein in an open, unliganded state than the closed-state
(Bao and Duong, 2013).
The Post-translocation Conformation
The key features of the post-T state are as follows: an open, unliganded binding
protein is bound to the transporter; the two TMDs of the transporter are inward-
facing; the two NBDs are semi-open and ADP and Pi-bound.
It was shown via EPR studies that when the complex is stabilized, using non-
hydrolyzable MgATP analogs or ATP in the absence of Mg, the binding protein
is in the open state and bound to the transporter (Austermuhle et al., 2004). The
importance of this feature is supported by the results of the Duong group, which
suggest that the bound binding protein stimulates ATP hydrolysis (Bao, Dalal, et al.,
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2015). Hydrolysis will provide energy for conformational change and substrate
translocation.
The inward-facing orientation of the TMDs is supported by X-ray crystallography
structures of the post-T state of themaltose transporter (Oldham and J. Chen, 2011b).
This state was stabilized by ADP in conjunction with phosphate analogs. The two
halves of the now inward-facing TMDs were shown to form a substrate binding site
that occludes a maltose molecule.
To stabilize the post-T complex, the products of hydrolysis (i.e. ADP and Pi)
must be trapped within the NBDs. Therefore, the nucleotide state of the post-T
conformation requires both ADP and Pi. ADP alone is not enough to stabilize a
transporter complex (Orelle, Ayvaz, et al., 2008; Karpowich et al., 2001; G. Lu
et al., 2005). The release of Pi triggers the opening of the NBDs; we saw in the
inward-facing conformation of MetNI, that the NBDs are ADP-bound (with Pi has
been released) and open (Kadaba et al., 2008).
In conclusion, after the important molecular event of substrate translocation, the
separation of the NBDs helps to reset the transporter for a new cycle. It is predicted
that the release of ADP and Pi destabilizes the closed NBDs. As soon as ADP and
Pi are released, the NBDs further widens to allow ATP to reload the transporter.
The Inward-facing Conformation
The inward state is distinct from the pre-T, outward, and post-T states in that the
binding protein has dissociated. The two TMDs are inward-facing while the NBDs
are open, in either nucleotide-free or ADP-bound form.
Three structures (2ONK, 3D31, 3DHW) of the inward-facing conformation have
nucleotide-free NBDs (Johnson et al., 2012; Kadaba et al., 2008; Pinkett et al.,
2007; Khare et al., 2009). However, one of the structures for the inward-facing
conformation of MetNI shows that ADP is bound (Johnson et al., 2012). This could
be because the inward state can be stabilized in a range of NBD separations, as
well as nucleotide states (Kadaba et al., 2008). Importantly, the observation of the
bound ADP to the MetNI inward-state suggests that the dissociation of Pi triggers
separation of the NBDs and shift the transporter to the inward facing conformation.
EPR studies also show that the NBD interface is open when no nucleotide is bound
(Orelle, Ayvaz, et al., 2008). After the release of ADP and Pi, the NBDs become
open and free to bind ATP to start a new cycle.
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Type II ABC Importers
During the substrate translocation cycle, the conformations for Type II are distinctly
different from Type I. The cycle starts with the outward state, proceeds to the inward
state, to the post-translocation state to resting state.
The outward-facing conformation
The outward-facing state has closed ATP-bound NBDs. The periplasmic gate of
the TMDs (i.e. the peri-gate (Locher, 2016)) are open, hence, this state is called
"outward-facing". Since the outward state is not bound to a binding protein, it is
not ready for substrate translocation. However, the closed-, ATP-bound NBDs are
poised for ATP hydrolysis; this explains why Type II importers have high basal rates
of hydrolysis (Borths et al., 2005).
It is predicted that the transporter is ATP-bound (Locher, 2016) even though there
are structures of outward-facing conformation with nucleotide-free NBDs for the
BtuCD (Locher, Lee, and Rees, 2002).
The Inward-facing conformation
The binding of a liganded binding protein to the outward state of the transporter
triggers a conformational change to the inward state in order to facilitate substrate
translocation. Consequently, the peri-gate is closed. In this state, the transporter has
closed, ATP-bound (ATP analog, AMP-PNP) NBDs; the TMDs have rearranged,
and space is made available to occlude a substrate (Korkhov, Mireku, and Locher,
2012). The transporter is now in complex with an apo binding protein as the
substrate has translocated to the TMDs (R. J. P. Dawson and Locher, 2006).
The post-Translocation Conformation
Upon ATP hydrolysis, the transporter adopts the post-translocation state. This
state has semi-open, ADP- and Pi-bound NBDs in association with an open, apo
binding protein. It is predicted that at this state, the substrate is still bound in
the translocation pathway site. This conformation corresponds to the complex at
1.76 × 10−11 m measured by SPR (Lewinson et al., 2010) with ATP, Mg2+, and
vanadate.
Subsequently, the dissociation of the open, apo binding protein promotes the trans-
porter to return to the outward conformation, which is ready to load ATP molecules
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for a new cycle.
The resting Conformation
The transporter can also adopt the resting state, where it is bound to an open,
unliganded binding protein (Locher, Lee, and Rees, 2002). It is substrate-free and
nucleotide-free.
This conformation corresponds to the complexwith the highest affinity at1.16 × 10−13 m
measured by SPR (Lewinson et al., 2010). Only one condition, (ADP + Mg+2 gives
the same level of magnitude as BtuCD-F alone (Rees, Johnson, and Lewinson,
2009). Since ADP alone does not stay stably within the NBDs without Pi, what
is most likely being measured here is BtuCD forming a complex with BtuF in the
absence of all additives. A new transport cycle starts when the dissociation of the
open, apo binding protein promotes the transporter return to the outward-facing
conformation.
2.4 The Advantages of a Binding Protein
In general, transport does not require a binding protein. ABC exporters and bind-
ing protein independent variants of mature ABC transporters do not have binding
proteins (Treptow and Shuman, 1985). Neither do secondary active transporters
that move solutes toward a higher concentration via symport or antiport of another
solute, which moves down the concentration gradient. For instance, LacY, which is
a symport of a galactoside and H+ does not have a binding protein. What do ABC
exporters and secondary active transporters have in common that compensates for
the lack of a binding protein?
We propose that a possible role of a binding protein is to sequester substrate in order
to increase the local concentration of the substrate to make it favorable for transport
(Piperno and Oxender, 1968). Sequestering substrate is especially necessary when
substrate concentration is low. This is similar to hemoglobin binding to oxygen,
when binding of O2 to a carrier protein increases the total concentration beyond
that of the solubility limit of O2 in water. We propose that ABC importers rely on
binding proteins to increase the local substrate concentration for transport.
We propose a secondary explanation that an importer can be promiscuous when it
comes to its association to binding proteins; importers can be paired with multiple
binding proteins, each of which binds to a range of substrates for transport. This
pairing system enables an importer to translocate a variety of substrates so that
29
cells can be energetically conservative in integral membrane motors synthesis and
instead rely on multiple smaller size soluble binding proteins. For instance, Gould
and Shilton usedmutant sMBP that bind to eithermaltose and sucrose to demonstrate
the ability of sMBP to stimulate ATP hydrolysis as being essentially the same as
wild-type MBP, suggesting that the substrate possibly not interact extensively with
the transporter during the cycle. It is between the transporter and the binding
protein that determines the transport. As such, it is possible that the transporter
would interact with a binding protein with little to no regard for what the substrate
is (Gould and Shilton, 2010).
As to why ABC exporters do not have a binding protein, exporters move solutes
from inside the cell to the outside. The volume of a cell is a small definite space.
Therefore, the exporters have an intrinsic mechanism to increase local substrate
concentration. Importers, however, transport solutes from outside the cell through
the the periplasm to the cytoplasm. Since the outer membrane is semi-permeable,
the space where the substrate is for importers is infinite.
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C h a p t e r 3
THERMODYNAMIC ANALYSIS OF METNI INTERMEDIATE
STATES
3.1 Introduction
ATP-binding cassette (ABC) transporters comprise one of the largest, ubiquitous
superfamilies of integral membrane proteins (Linton and Higgins, 1998; Ames et
al., 1992). These integral membrane proteins derive energy from ATP binding
and hydrolysis to drive the active transport of a variety of substrates across the
membrane.
Though the proper function of ABC transporters is important to many biochemical
processes, the mechanism of transport has been elusive. An extensive body of
qualitative experimental data supports a "two-state, alternating access" model that
depicts two major conformations. Each conformation has a substrate binding site—
formed by a specific arrangement of the two TMDs—which opens towards one side
of themembrane or the other (Jardetzky, 1966). The translocation of substrate across
the membrane is achieved through conformational changes coupled to nucleotide
state.
Structural studies have informed us about four specific arrangements of the trans-
porter during the transport cycle (J. Chen et al., 2001; Oldham, Khare, et al., 2007;
Khare et al., 2009; Orelle, Alvarez, et al., 2010; Oldham and J. Chen, 2011b; Oldham
and J. Chen, 2011a; Jin et al., 2012; Locher, Lee, and Rees, 2002; Korkhov, Mireku,
and Locher, 2012). First, the pre-translocation (pre-T) conformationwas determined
to have semi-open NBDs that associate with a closed binding protein. Second, the
outward-facing (outward) conformation of the transporter has closed, ATP-bound
NBDs that associate with an open binding-protein. Third, a post-translocation (post-
T) conformation was determined to have ADP+Pi-bound NBDs that associate with
an open binding-protein. Lastly, the inward-facing (inward) conformation has open,
nucleotide-free NBDs and is not associated with a binding protein. Considering the
structural conservation of the NBDs in these intermediates, NBDs must play a vital
role during the transport cycle.
With this background in mind, we begin our discussion of MetNI, an ABC trans-
porter. The import mechanism developed for MetNI has benefited from the knowl-
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edge of other systems, like the maltose and vitamin B12 ABC transporters. Here, we
studyMetNI in detail, aiming to elucidate its mechanism. Because of the homology,
we hope the MetNI mechanism has predictive power towards other ABC importers.
MetNI is present in E. coli, a gram-negative bacteria (Kadner and Watson, 1974),
which are distinguished by their double membranes. The double membranes consist
of an inner membrane, outer membrane, and the periplasm, the region separating
the two membranes. The outer membrane is porous and highly permeable—due
to the presence of porins and related molecules—and serves as the entry-point for
nutrient-substrates, like amino acids and vitamins. In contrast, the inner membrane
forms a permeability barrier that, with the exception of a few small, non-polar
molecules, impedes the passage of virtually all molecules into cells.
Nutrient-substrates, like L-methionine, can only gain entry into cells through the
action of transporters, likeMetNI. These transporters are integralmembrane proteins
that sit in the inner membrane and move substrates from the periplasm to the
cytoplasm. Most substrates transported by ABC importers are in low concentration
in the environment, which makes it difficult for transporters to secure nutrients for
transport. Predictably, importers have ways to address this shortcoming.
Transporter binding-proteins, likeMetQ, can diffuse freely in the periplasm and have
a high affinity for nutrient-substrates (Kellermann and Szmelcman, 1974; Ferenci
et al., 1986). For example, when a binding protein captures a substrate under
physiological conditions, the high affinity means it is favorable for L-methionine
to be bound to MetQ—in all the conditions we have tested, other than through
the transport process, MetQ releases L-methionine only under refolding conditions.
Therefore, binding proteins help serve as a sequestering agent for transporters and
gather much-needed nutrient substrates.
MetQ serves two major functions for MetNI. First, MetQ acts to sequester nutrient-
substrates when they enter the periplasmic space. Second, it delivers methionine to
theMetNI transporter to create a uni-directional mechanism tomove substrates from
the periplasm into the cytoplasm. The affinity of MetQ for methionine is clearly
critical to fulfilling these functions and therefore, we aimed to quantify MetQ’s
affinity for L-methionine experimentally.
MetQ binding to L-methionine is only the beginning of transport, and we wish
to characterize the transport mechanism further. Therefore, we characterized and
isolated certain intermediate states of MetNI during the transport cycle and used
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this information to propose a kinetic model of ABC transporter function. We used
SPR and MST to study the dynamics and energetics of the transport cycle.
Based on this analysis of the interactions of MetQ with MetNI and L-methionine
under different conditions, we develop a transport mechanism that is a synthesis of
previous experimental observations and present kinetic and thermodynamic char-
acterizations. With this approach, we quantified the nature of the translocation
states, measured the affinities for substrate binding sites, and analyzed the nature of
the regulatory transinhibition mechanism. Overall, we are interested in exploring:
(1) L-methionine binding to MetQ (2) the kinetics and equilibrium constants for
the formation of major intermediate conformations of the transporter during sub-
strate translocation, (3) the mechanism for transinhibition, and (4) the advantages
of having a binding protein.
We used SPR and MST because both techniques provide quantitative measurements
of the relative stabilities of different conformations. SPR, in particular, can measure
the rate constants of complex association and dissociation; as well as affinities. MST
provides affinity data, not kinetic data; however, an MST setup is different from the
SPR microfluidics setup and enables us to measure reactions that are not possible
with SPR.
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Figure 3.1: L-methionine binding MetQ decreases the stability of the MetNI-
MetQ complex. The effect of L-methionine on the MetNI-MetQ system was
examined by comparing the kinetics of this complex between ATP- and ATP+L-
methionine-containing buffer. By comparison, L-methionine increases the rate
constant of dissociation, therefore decreases the complex stability. Panel (a) mea-
surement was done by immobilizing the unfolded-refolded MetQ (an equivalence of
100 R.U. of MetQ) on a Biacore sensor-chip. For the first 700 seconds of the assay,
varying concentrations of the construct E166Q MetNI (varying from 1 to 1000 nm)
were solubilized in the running buffer (0.025%DDM, 25mm TAPS pH 8.5, 250mm
NaCl, 1mm ATP, 1mm EDTA) and injected to allow interaction with MetQ. The
following 700 seconds was a washing step with the aforementioned running buffer.
Panel (b) measurement was done with the above SPR setup and the following buffer
condition: 0.025% DDM, 25mm TAPS pH 8.5, 250mm NaCl, 1mm ATP, 1mm
EDTA, and 1mm L-methionine. Each measurement was done in triplicate (see
"Experimental Procedure").
3.2 Results
L-methionine binding to MetQ
We wanted to measure the binding affinity of L-methionine to MetQ. However, as
discussed below, a method that directly measures this interaction was not avail-
able. Therefore, we designed an indirect SPR assay while taking some factors into
consideration. First, MetQ and L-methionine are not a good ligand-analyte pair
for Biacore kinetic assays—the molecular weight change when methionine binds to
MetQ is insufficient to detect by SPR. Second, MetQ binding to L-methionine could
not be observed with MST—the change in size, charge, and hydration shell of MetQ
upon binding to L-methionine is also insufficient to generate a thermophoresis pro-
file compared to apo-MetQ. Third, the binding affinity of MetQ and L-methionine
was too high to study using isothermal titration calorimetry. Therefore, to probe
this interaction, we need to look at how L-methionine binding to MetQ affects the
MetNI-MetQ system.
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It turns out that L-methionine binding to MetQ decreases the stability of the MetNI-
MetQ complex. Size exclusion chromatography studies show that the co-purified
L-methionine in MetQ decreases the complex’s affinity (Nguyen et al., 2015). Our
Biacore observations confirmed this notion (Figure. 3.1). In a Biacore assay, MetNI
is solubilized in a running buffer containing 1mm L-methionine. When this L-
methionine containing buffer flows over the immobilized apo MetQ, it caused the
complex to rapidly dissociate, showing that L-methionine destabilizes the MetNIQ
complex. Therefore, we used the MetNIQ complex as a readout for measuring
L-methionine binding to MetQ.
L-methionine has three potential binding sites with a complex: MetQ, theMetNI C2
domain, and potentially the MetNI translocation-pathway. Consequently, we used
mutations that inhibit the binding of L-methionine to the other two sites to specif-
ically examine binding to MetQ. We used mutation N295A (mutant contributed by
P. Nyugen)—located in the C2 domain and prevents L-methionine from binding to
C2—to study the interaction betweenMetQ and L-methionine. There is nomutation
available to silence the translocation-pathway binding to L-methionine. However, it
is likely that this site has a very low affinity to the substrate, since it has never been
observed crystallographically and binding to L-methionine occurs predominantly in
the C2 site once the MetQ site is mutated. Therefore, we created conditions that
allowed us to inspect the L-methionine site in MetQ.
The second obstacle to measuring MetQ binding L-methionine is that wild-type
MetQ co-purifies with L-methionine. This co-purification implies that the MetQ
sites are occupied at the start of any experiments, which prevents titrated L-
methionine from binding to MetQ. Therefore, we used a high concentration of
guanidinium chloride to unfold and then refold MetQ (the unfolded-refolded "Lo"
construct of MetQ), which stripped away the bound L-methionine. This process
makes the MetQ site available for binding L-methionine.
It is important to establish that the unfolded-refoldedMetQ construct has no artifacts
that resulted from the unfolding process. We can confirm this by demonstrating
that MetQ devoid of L-methionine—via either being washed-away or unfolded-
refolded—retains its activity. It has shown that both N229A MetQ and unfolded-
refolded MetQ binds to E166Q MetNI with comparable affinities in SPR as well as
MST measurements.
In our setup, a constant concentration of transporter flowed above the immobilized
MetQ. Based on our observation and upon association of ligandedMetQ toMetNI—
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in the presence of ATP—the co-purified L-methionine should be transported and
washed away in the SPR microfluidic channel. This implies that the majority of
MetQ should be in apo form after the first several runs with MetNI.
L-methionine being washed away explains why the wild type MetQ binds to MetNI
with the same affinity as the unfolded-refolded MetQ or the N229A MetQ—both
constructs are largely devoid of L-methionine (Figure 3.2). The possibility of L-
methionine washing away from wild-type MetQ also explains why we observed
complexes with the same affinity and kinetic profile whether we started with apo- or
liganded-MetQ. The fact that any of the three MetQ constructs always produces a
MetNI-MetQ complex with the similar affinities suggests that MetQ is apo because
apo MetQ forms a higher affinity complex than liganded MetQ (data shown in MST
study below). Therefore, it does not matter whether L-methionine is bound to MetQ
at the start of each measurement, as it will dissociate and open up the binding site.
SPR k1 k−1 k2 k−2 Kd
Unit m−1 s−1 s−1 s−1 s−1 m
N229A MetQ (Red Curves) 2.3 × 103 8.0 × 10−3 8.6 × 10−3 1.6 × 10−4 6.5 × 10−8
Regular MetQ (Blue Curves) 1.8 × 103 8.8 × 10−3 9.6 × 10−3 2.4 × 10−4 1.2 × 10−7
Unfolded Refolded MetQ (Green Curves) 2.2 × 103 1.2 × 10−2 8.8 × 10−3 2.4 × 10−4 1.2 × 10−7
Table 3.1: Different variants of MetQ behave similarly kinetically. According to
the two-state model, k1 and k−1 are the forward and reverse rate constant for MetNI-
MetQ complex formation, respectively. k2 and k2 are the forward and reverse rate
constant for an isomerization step, respectively. Kd is the dissociation constant for
MetNI and MetQ forming MetNI-MetQ according to the Equation 3.2.
We developed the following approach to measure the effect of L-methionine binding
to MetQ. We used transporter mutant E166Q MetNI for all of the following assays.
MetNI contains a glutamic acid in the Walker B region that takes an active part
in facilitating hydrolysis, and the ATPase activity can be significantly inhibited by
substitution of this residue by a glutamine (Moody et al., 2002). Mutant E166Q
MetNI has been shown to have a 20-fold reduced rate of hydrolysis (work by J. Yang,
unpublished). In combination with saturating concentrations of ATP and EDTA,
this mutant has been used in other ABC transporters to stabilize the ATP-bound
NBDs.
To perform the designed assay, we established a readout by forming a stable complex
between the ATP-bound N295A E166Q MetNI and unfolded-refolded MetQ; we
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Figure 3.2: Different variants ofMetQ binds toMetNI with the same affinity. In
SPR studies, the affinity of the MetNIQ complex is the same with all three variants
of MetQ: (a) Liganded MetQ: wild-type MetQ with co-purifying L-methionine,
Kd 1.20 × 10−7 m; (b) Unliganded MetQ: MetQ has been unfolded and then refolded
to strip away co-purifiedL-methionine,Kd 1.27 × 10−7 m; and (c)UnligandedMetQ:
N229AMetQ, Kd 0.65 × 10−7 m. In addition to their comparable affinity, the kinetic
profiles are also the same. This indicates that all three versions of MetQ, despite
having different ligand states when immobilized, end up having the same ligand state
in the recorded results. We believe that the L-methionine has been washed away
after a few measurements in the SPR microfluidic channel. Experimental setup: on
the four channels of the sensor chip, the following were immobilized respectively:
the control BtuF, wild-type MetQ, unfolded-refolded MetQ, and N229A MetQ. A
constant concentration of E166Q MetNI solubilized in the running buffer (25mm
TAPS, pH 8.5, 250mm NaCl, 0.025% DDM, 1mm ATP, and 1mm EDTA). E166Q
MetNI was injected to interact with MetQ in a time- and speed-controlled manner.
After each injection, a glycine solution of pH2was used towash off the boundE166Q
MetNI. MetQ was tested to be stable under this washing condition. Measurements
with each MetQ construct were done in triplicates. This procedure was done for
each of the Biacore experiments discussed in the text.
then titrated in L-methionine. First, we immobilized unfolded-refolded MetQ on a
Biacore (GE Healthcare) carboxymethylated dextran sensor chip. A covalent bond
is formed between the primary amino groups (RNH2) of MetQ via the NHS/EDC
activated carboxylate group on the chip. Following immobilization, we titrated L-
methionine—along with a constant concentration of E166Q MetNI in each titration
injection (solubilized in detergent (0.025% DDM) containing 1mm ATP and 1mm
EDTA)—onto the flow cells. As a control, we flowed 1000 nm E166Q MetNI
over MetQ in the same buffer but without any L-methionine. This obtained a
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Figure 3.3: The Kd for L-methionine binding to MetQ is 1 × 10−8 m. To measure
the binding affinity of L-methionine to MetQ, wild-type MetQ was immobilized on
a sensor-chip. A binding curve was generated by titrating varying concentrations
of L-methionine, with each titrant having the same concentration of E166Q MetNI
(1 µm), solubilized in the running buffer (25mm TAPS, pH 8.5, 250mm NaCl,
0.025% DDM, 1mm ATP, and 1mm EDTA). The black line is generated with the
use of the E166Q MetNI; The green line is generated with the double mutant of
N295A E166Q MetNI. For both curves, at around 1 × 10−8 m, half of the MetNI-
MetQ complex dissociated. There are potentially three binding sites with the E166Q
MetNI: MetQ, TMD, and C2. It is predicted that the 1 × 10−8 m is the affinity for
MetQ binding L-methionine since the TMD, and C2 sites havemuch lower affinities.
robust response representing complex formation. Once the injection was terminated
at 700 seconds and the washing buffer was started, the complex was stable and
did not dissociate. This indicates that a stable MetNI-MetQ was formed with
saturating concentrations of ATP and EDTA in the absence of L-methionine. With
L-methionine titration, the complex level decreases.
The assay results (Figure. 3.3) showed that MetQ binds L-methionine with high
affinity. We did two experiments to confirm the affinity. The first measurement
(black curve) is when wild-type MetQ was immobilized with E166Q MetNI (sol-
ubilized in the running buffer mentioned above) with varying concentrations of
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L-methionine. The second measurement (green curve) is the same as the first ex-
periment, except that N295A E166Q MetNI was used. Both binding curves show
biphasic characteristics and are better described by fitting each phase separately
(see Materials and Methods, Section 3.4). For both binding curves, the first binding
phase was fitted to the Hill equation and the binding affinity was characterized to
7.2 nm; the second phase was fitted as a linear curve on a semi-log scale and is in
the range of 100–10 000 nm. The 7.2 nm is assigned as the affinity of MetQ binding
L-methionine. The lower affinity in the range of ∼ 10 000 nm is thought to be the
potential translocation pathway binding L-methionine or the binding of Met to the
C2 domain.
Characterization of Intermediate States of the Transport Cycle
Following substrate binding to MetQ, the rest of the transport cycle involves confor-
mational changes from an apo transporter to several intermediates. Since transport
is a continuous process, we partitioned it into several major transitions for analysis.
For each transition, we characterized the physical characteristics of the transport
intermediates. We evoked the characteristics of these species and came up with
strategies to stabilize intermediate states with these properties. We then identified
biophysical techniques that can best measure the information desired.
We discuss the four, previously-described conformational-states: pre-T, outward,
post-T, and inward conformation. Three of these conformations—pre-T, outward,
and post-T—are transporter-complexes that have formed a complex with the binding
protein. Only the pre-T conformation is bound to a liganded binding-protein. The
pre-T state and the outward state are ATP-bound, while the post-T state is ADP- and
Pi-bound.
To begin our analysis, we first define the different conformations of the TMDs. The
L-methionine binding site formed by the TMDs is called the translocation pathway
substrate binding site (’translocation pathway site’). The alternating access model
stipulates that there are two major conformations by the opening formed by these
two domains and the orientation of the opening with respect to which side of the
membrane (Jardetzky, 1966). The outward-facing orientation of the TMDs is such
that the domains form a cavity, which opens to the periplasm. The inward-facing
TMDs is such that the cavity opens to the cytoplasm. The model further states that
the affinity of the translocation pathway site for the substrate is different between
the two conformations. It is predicted that when the TMDs are in the outward-
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facing orientation, the affinity for the substrate is higher than the inward-facing
orientation. The switch to a lower affinity for substrate creates an optimal condition
for L-methionine to be dissociated once the translocation pathway site is in the
inward-facing conformation.
We constructed a kinetic model (Figure 2.1) that incorporates our analysis and
previous experimental observations.
The Pre-Translocation Conformation
Figure 3.4: The dissociation constant for liganded- and unliganded-transporter
complex The affinity of MetNI for MetQ was measured by titration curves using
fluorescently labeledMetQ—in the presence or absence of bound methionine (wild-
type or N229A MetQ, respectively). All experiments contained 1mm ATP and
1mm EDTA. 101 nm of Cy3-labeled, wild-type MetQ was titrated with 1.95 nm -
32 µm non-labeled E166Q MetNI (closed squares). 99 nm of Cy3-labeled N229A
MetQ was titrated with 1.95 nm - 4 µm non-labeled MetNI E166Q (open circles).
The dissociation constants calculated from these data for wild-type (methionine-
bound) and N229A (methionine-free) MetQ binding to E166Q MetNI are Kd =
(1100 ± 300) nm and (27 ± 9) nm, respectively. Error bars represent standard error
from three independent measurements.
The pre-translocation conformation poises the transporter for ATP hydrolysis and
substrate translocation. Previous structural work showed that pre-T has semi-open
NBDs (Oldham and J. Chen, 2011a). Additionally, the TMDs are predicted to be
in the inward-facing orientation (Oldham and J. Chen, 2011a). In our experiment,
we showed that ATP is required to form the pre-T state (Figure 3.6). Therefore, the
prominent features of this conformation are as follows: TMDs are inward-facing and
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bound to a liganded MetQ, and two NBDs are semi-closed. ATP might be bound
to either or both halves of the NBDs. In either scenario, since the NBDs are not
closed, the transporter is not ready for hydrolysis. We stabilized this conformation
under experimentally defined conditions.
First, we showed that ATP is required to stabilize the pre-T state. Since MetNI
only has two ATP binding sites in the NBDs, we proposed that either or both sites
are occupied by ATP. To probe the pre-T’s nucleotide state, we established the
MetNI-MetQ complex’s SPR profiles under different nucleotide states. Then we
compared the stabilized pre-T against each profile and ascertained the nucleotide
state of pre-T. This process began by immobilizing unfolded-refolded MetQ. Fol-
lowing the immobilization, we injected E166QMetNI (solubilized in 0.025% DDM
containing 1mm EDTA) and 1mm of different nucleotide (ATP, ADP, ADP+Pi, Pi,
vanadate, ADP+vanadate, or nucleotide-free) for each measurement onto the flow
cells. When we flowed 1000 nm E166Q MetNI over MetQ—in the presence of
ATP—we obtained a robust response representing complex formation. Once the
injection was terminated (i.e. the washing buffer started), the complex was stable
and did not readily dissociate. However, when we flowed 1000 nm E166Q MetNI
in the presence of the nucleotides mentioned above, other than ATP over MetQ, no
complex formation was observed. This result was observed even when MetNI was
in several-fold molar excess of MetQ. This means a complex formation signal in
SPR shows that the MetNI-MetQ complex requires ATP.
Previously, we showed that in our SPR setup, L-methionine inMetQ is washed away
after the first few measurements. That means we would not be able to stabilize the
pre-T state, which has a liganded MetQ. Therefore, we tried to stabilize it in an MST
assay. We reasoned that the bound L-methionine would not get dissociated from
MetQ in a solution in the absence of a constant flow of MetNI. Use of wild type
MetQ—which contains co-purified L-methionine—stabilized the pre-T conforma-
tion. L-methionine remained bound to MetQ in solution, versus a constant flow of
solution in a Biacore channel, as shown by x-ray crystallography work.
Importantly, we reasoned that a binding protein forms a complex with the transporter
at a higher affinity when the TMDs of the transporter are in the outward-facing
orientation because there is more surface interaction of the TMDs with the binding
protein. Studies in the maltose system suggest that the interaction between liganded
binding-protein and the transporter trigger the release of the ATP products ADP
and Pi (Bao, Dalal, et al., 2015). It is predicted that MetNI binds to liganded MetQ
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first, forming Pre-T. As the MetQ-bound ligand stimulates hydrolysis, the pre-T is
promoted to quickly adopt a conformation that is most suitable for hydrolysis (i.e.
the outward-facing conformation). Therefore, pre-T converts to the outward facing
conformation upon binding ATP. After this isomerization, the complex achieves the
highest affinity, which allows hydrolysis and substrate translocation to occur.
We determined the affinity constant for the binding ofMetNI toMetQ in this complex
to be 1100 nm (Fig. 3.4), which is 40-fold lower than that of the outward conforma-
tion (27 nm as measured and discussed in section 3.2). With the observations that
complex formation is ATP-dependent, we confirmed the successful stabilization of
the pre-T intermediate by the process of elimination. We reasoned that since this
state is ATP-required, it can be either pre-T or outward—a post-T transporter is ADP
and Pi-bound during hydrolysis. Additionally, we know that the pre-T conformation
should bind liganded MetQ, as discussed previously. We verified the pre-T identity
with this comparative MST assay (Figure. 3.4).
The Outward-facing Conformation
Aspreviously discussed, L-methionine is bound toMetQ—complexedwithMetNI—
in the pre-T state. In that state, the translocation pathway site is inward-facing. We
propose that the closed L-methionine bound conformation of MetQ triggers the
change in conformation of the TMDs from inward to outward. Subsequently, L-
methionine dissociates from MetQ and binds to the outward-facing translocation
pathway substrate site. In addition to the outward-facing TMDs, the NBDs of
MetNI in the outward state are predicted to be closed. Therefore, MetQ is predicted
to be open and unliganded in the outward conformation of MetNIQ. The structure of
the MalFGK2 outward-facing conformation shows that the substrate is absent from
the binding protein (Oldham, Khare, et al., 2007). Additionally, EPR studies show
that the two lobes of the binding protein are separated from each other (Austermuhle
et al., 2004). Combining these observations, we used unfolded-refolded MetQ to
ensure that MetQ is in the open, unliganded state to prepare the outward-facing
conformation.
In summary, the essential elements of an outward-facing conformation of an ABC
transporter are as follows: (1) the TMDs are open to the periplasm, and hence
’outward-facing’; (2) the NBDs are close to each other and ATP-bound. For ABC
importers that are dependent on a binding protein for transport, in the outward state,
the transporter is bound to the binding protein. Therefore, the third element is (3)
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MetNI is bound to MetQ. (4) During a productive transport, substrate L-methionine
should be released to the translocation pathway site. However, it is uncertainwhether
this fourth element—substrate bound to the translocation pathway site—is necessary
to trigger an outward state of the transporter. For instance, structural work on the
maltose transporter shows that substrate is bound to the translocation pathway site
during the pre-T state. Chen and co-workers concluded that their observation is due
to the high concentration of the substrate in the solution (Oldham, S. Chen, and
J. Chen, 2013).
We believe the conditions in our SPR experiment (Figure 3.6) trapped a conformation
of MetNI that closely resembles the outward state. In this experiment, the trapped
conformation of MetNI forms a complex with MetQ and the TMDs are outward-
facing; however, there is no substrate bound to any substrate site in the MetNIQ
complex. We reasoned that the translocation binding site is trapped in the outward-
facing orientation because there is an excess of EDTA that prevents ATP hydrolysis
by chelating the Mg2+ cofactor. Biophysical data from the Chen group show that
when the maltose transporter is in the outward-facing conformation, it is associated
with the binding protein and its NBDs are ATP-bound (Orelle, Ayvaz, et al., 2008).
Because an association with both ATP and MetQ is essential, we first studied the
ATP dependence of the MetNIQ complex to examine the conditions necessary to
establish ATP-bound NBDs. We then studied the kinetics of the MetNIQ complex
formation.
The molecular events that happen in the outward state are predicted to be coupled so
that hydrolysis couples with substrate translocation and the conformational change
fromoutward to post-T. Therefore, ATPmust be poised for hydrolysis by being bound
to the closed NBDs, a condition necessary a priori for all three events mentioned
above.
In order to simulate these reactions, we first determined the concentration of ATP
required to support complex formation. We measured the concentration of ATP
required to get half maximal formation of the MetNIQ complex on the Biacore
chip. The concentration was determined to be 50 µm (Figure 3.5) when half of
the immobilized MetQ is complexed with MetNI. The ATP-hydrolysis-defective
E166Q MetNI mutant was used in combination with saturating concentrations of
ATP and EDTA. Consequently, the use of 1mm ATP ensures that most transporters
are ATP-bound.
In addition to ensuring that the NBDs are ATP-bound, we needed to figure out
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Figure 3.5: The ATP dependence of the MetNI-MetQ complex formation. For
the assay, the unfolded-refolded MetQ was immobilized on the sensor-chip, Varying
concentration (0 - 1mm) of ATP with a constant concentration of MetNI (1 µm
E166Q MetNI solubilized in 0.025% DDM, 20mm TAPS pH 8.5, 250mm of NaCl,
and 1mm EDTA was titrated to the immobilized MetQ. It is found that at 50 µm of
ATP, half of the MetNI-MetQ complex is ATP-bound.
the conditions that stabilize closed NBDs. There is controversy on the necessary
conditions required for the closure of NBDs. In Bao and Duong (2013), the Duong
group concluded that NBDs close upon ATP binding. However, in Orelle, Ayvaz,
et al. (2008), the Davidson group reasoned that both ATP binding to the NBDs and
the transporter interacting with a binding protein are required. Since we already
ensured ATP-bound NBDs, we need only establish that binding-protein interactions
occur to be certain of stabilized, closed NBDs according to either group’s finding.
In detail, as seen in Equation 3.1, this reaction describes apo MetQ, designated as
’Q’ in the model, binding to ATP-bound E166QMetNI, designated by ’ET’, to yield
’ETQ’. ’ETQ’ then converts to ’ETQ*’ . ’ETQ*’ is believed to be the conformation
before hydrolysis, the outward-facing state. The binding curves in the experiment
shown in Figure 3.6 were fitted using the Two State model (see section 3.4 for model
description and fitting), which describes a 1:1 binding interaction followed by an
isomerization step. k1 and k−1 are the forward and reverse rate constant for MetNIQ
complex association and dissociation, respectively. k2 and k−2 are the forward and
reverse rate constant for conformational change, respectively.
ET + Q k1k−1 ETQ
k2
k−2 ETQ
* (3.1)
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Figure 3.6: Kinetic Characterization of the outward-facing conformation. Each
colored curve is an experimental binding curve. The binding curves were fitted us-
ing the Two State model (see section 3.4 for model description and fitting), which
describes a 1:1 binding interaction followed by a isomerization step. k1 and k−1
is the forward and reverse rate constant for complex association and dissociation,
respectively. k2 and k−2 are the forward and reverse rate constant for conforma-
tional change, respectively. The k1 is 5.6 × 103 m−1 s−1, k−1 is 7.4 × 10−5 s−1, k2
is 1.7 × 10−3 s−1, k−2 is 1.2 × 10−2 s−1, and Kd is 1.1 × 10−8 m. In this assay, the
unfolded-refolded MetQ was immobilized on a sensor-chip. The chip was then
equilibrated with a running buffer: (25mm TAPS, pH 8.5, 250mm NaCl, 0.025%
DDM, 1mm ATP, 1mm EDTA). E166Q MetNI (Lm construct) of varying concen-
trations (range from 1 to 1000 nm) was injected to interact with MetQ in a time-,
and speed-controlled manner. After each injection, a glycine solution of pH 2 was
used to wash off the bound E166Q MetNI. MetQ was tested to be stable under this
washing condition.
Kd =
k−1
k1
× k−2
k−2 + k2
(3.2)
The association and dissociation curves showed biphasic characteristics, as expected,
to reflect an isomerization step following the binding step (Figure 3.6). Therefore,
we fitted the data to a two-state model to account for these results. Under the ex-
perimental conditions, E166Q MetNI forms a complex with apo MetQ with a k1 of
5.6 × 103 m−1 s−1, k−1 is 7.4 × 10−5 s−1, k2 is 1.7 × 10−3 s−1, k−2 is 1.2 × 10−2 s−1
and Kd is 1.1 × 10−8 m according Equation 3.2. k1 and k−1 are the forward and
reverse kinetic rate constants for complex formation and dissociation, respectively.
k2 and k−2 are the forward and reverse rate constant for conformational change, re-
spectively. The Biacore binding assay showed that the outward-facing conformation
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SPR k1 k−1 k2 k−2 Kd
Unit m−1 s−1 s−1 s−1 s−1 m
Constants 5.6 × 103 7.4 × 10−5 1.7 × 10−3 1.2 × 10−2 1.1 × 10−8
Table 3.2: The kinetic constants of the outward-facing state using SPR Ac-
cording to the two-state model, k1 and k−1 are the forward and reverse rate constant
for MetNI-MetQ complex formation, respectively. k2 and k−2 are the forward and
reverse rate constant for an isomerization step, respectively. Kd is the dissociation
constant for MetNI and MetQ forming MetNI-MetQ according to the Equation 3.2.
MST Kd
Constants 2.7 × 10−8 m
Table 3.3: The dissociation constant of the outward-facing state using MST.
This measurement is from the experiment shown in Figure 3.2
has a higher affinity than all other known Type I importer transporter-complexes
(Table 2.1). Also, the affinity of the outward state measured by SPR is similar to the
value measured by MST (Figure 3.3).
The Post-translocation State: Post-hydrolysis reaction simulation
SPR k1 k−1 k2 k−2 Kd
Unit m−1 s−1 s−1 s−1 s−1 m
Constants 9.8 × 103 m−1 s−1 9.1 × 10−4 s−1 3.3 × 10−6 s−1 9.5 × 10−3 s−1 9.3 × 10−8 m
Table 3.4: Nucleotide can exchange without the dissociation of binding protein.
According to the two-state model, k1 and k−1 are the forward and reverse rate
constant for MetNI-MetQ complex formation, respectively. k2 and k−2 are the
forward and reverse rate constant for an isomerization step, respectively. Kd is the
dissociation constant for MetNI and MetQ forming MetNI-MetQ according to the
Equation 3.3.
After translocation has occurred, MetQ must dissociate to reset the transporter.
MetQ dissociation is facilitated by the release of the ATP hydrolysis products. To
stabilize the post-T state, we must ensure the transporter is still MetQ-bound and the
hydrolysis-products are still intact. We learned to stabilize the post-T conformation
by recalling results from the maltose transporter. In these transporters, the vanadate-
stabilized, post-translocation state is formed by trapping the products of hydrolysis
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Figure 3.7: Mg2+ stimulates ATP hydrolysis. Each colored curve is an experi-
mental binding curve. In this assay, the unfolded-refolded MetQ was immobilized
on a sensor-chip. The chip was then equilibrated with a running buffer: ( 0.025%
DDM, 25mm TAPS, pH 8.5, 250mmNaCl, 1mmATP, 1mmMg2+). E166QMetNI
(Lm construct) of varying concentrations (range from 1 to 1000 nm) was injected to
interact with MetQ in a time-, and speed-controlled manner. After each injection, a
glycine solution of pH 2 was used to wash off the bound E166Q MetNI. MetQ was
tested to be stable under this washing condition.
in theNBDs (Sharma andDavidson, 2000). Other conditions that attempt to recreate
this trapped complex, such as adding ADP only, vanadate only, or ADP and vanadate
were unsuccessful. That means, the post-T must be trapped right after hydrolysis
and before ADP and Pi are released; adding the products of hydrolysis after the
original ADP and Pi have been released does not recreate the post-T state.
We learned that the basal rate of hydrolysis inmutant E166QMetNI can be stimulated
by the addition of Mg2+. Therefore, our experiment (Figure 3.7), which aims to trap
the MetNI post-T state, involves E166Q MetNI binding to MetQ in the presence of
ATP and Mg2+. In this experiment, both ATP and Mg2+ are present in the running
buffer. That means after each cycle of hydrolysis, the hydrolysis products (i.e. ADP
and Pi) can be replaced by the ATP in the solution. Here, we have a pool that
contains a mix of ATP- and ADP+Pi-bound transporters. This complex has an
affinity of 9.3 × 10−8 m (Table 3.4).
It is hypothesized that the hydrolysis defective transporter slows the release of ADP
and Pi, hence stabilizing the post-T state. Another piece of supporting evidence
is that the lack of bound substrate in the binding protein makes the release of Pi
47
Figure 3.8: ATP hydrolysis stimulates MetQ dissociation. The rate con-
stant of dissociation of the complex MetNIQ when hydrolysis is minimized is
1.2 × 10−4 s−1. The rate constant of dissociation when hydrolysis is stimulated by
Mg2+ is 1.1 × 10−2 s−1. MetQ dissociates slowly from the MetNIQ complex in
the presence of ATP and EDTA (green binding curve). If EDTA and ATP were
removed and Mg2+ was introduced, the dissociation is accelerated (blue binding
curve). The black and magenta curve are the fits according to the single exponential
decay function to the experiments mentioned above, respectively. In this assay, the
unfolded-refolded MetQ was immobilized on a sensor-chip. For the green binding
curve, 1 µm E166Q MetNI (Lm construct) solubilized in (0.025% DDM, 25mm
TAPS, pH 8.5, 250mm NaCl, 1mm ATP, 1mm EDTA) was flowing in the channel
to interact with the immobilized MetQ. For the blue binding curve, the same setup,
construct, and buffer condition was used, except EDTA and ATP was taken out and
Mg2+ was added.
rate-limiting (Bao, Dalal, et al., 2015). As such, we have reason to believe that
some products of hydrolysis are retained within the complex. The fact that we still
observed signals for complex indicates that we have trapped the post-T. The affinity
of the post-T state is roughly one order of magnitude lower than the outward state,
which is 1.1 × 10−8 m as seen in Table 3.2.
To further understand events after translocation, we designed an experiment (shown
in Figure 3.8) where there is no replacement of ATP after hydrolysis. In this
experiment, the green and the black curves are the buffers containing ATP and
EDTA. The blue and magenta curves show the destabilization of the MetNI-Q
complex stimulated byMg2+when there is noATP for replacement in the buffer. The
rate constant of dissociationwhen hydrolysis is stimulated byMg2+ is 1.1 × 10−2 s−1.
Since the rate constant of dissociation is the element that changes with the addition
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Figure 3.9: ATP can be replaced while the binding protein is bound to the
transporter. Here, a comparison of the dissociation phase of the MetNIQ complex
under three conditions: ATP, Mg2+, and ATP+Mg2+. With ATP, the complex
dissociates minimally. With ATP and Mg2+, the dissociation rate constant is faster;
and much faster with Mg2+ alone.
of Mg2+, this rate presumably reflects the rate of ATP hydrolysis.
Lastly, we compared the kinetics of the MetNIQ complex under three different
conditions in Figure 3.9. Under the condition of ATP+EDTA, which minimizes
hydrolysis; ATP+Mg2+, which stimulates hydrolysis and the products of hydrolysis
can be replaced by the ATP in the buffer; Mg2+, which stimulates hydrolysis,
however, the products of hydrolysis are still bound within the NBDs. We observed
that hydrolysis with replacement of ATP destabilized the complex, while hydrolysis
with no ATP replacement further destabilized the complex in comparison.
ETQ∗ 
 EDQ → ED + Q (3.3)
The Inward-facing conformation
After substrate translocation, a series of events occur that are important to es-
tablishing the resting state: the inward-facing conformation. The following ob-
servations increased our understanding of the sequence of events that happened
post-translocation. First, hydrolysis stimulated the opening of the NBD (Moody
et al., 2002); this is in agreement with the fact that the inward-facing state crystal
structure of MetNI exhibits open NBDs. Second, our SPR studies showed that
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hydrolysis prompts the dissociation of MetQ from MetNI (Figure 3.7). Based on
these observations, the sequence of events that occur is predicted to be as follows:
a liganded MetQ interacts with the transporter to trigger hydrolysis as discussed
in Section 3.2. Hydrolysis then resets the ATP-binding cassette dimer into the
resting-state conformation through the separation of the NBDs (G. Lu et al., 2005).
Subsequently, the opening of the NBDs prompts the releases of ADP and Pi. Fol-
lowing the release of these nucleotides, MetQ dissociates, prompting the transporter
to adopt the inward-facing conformation, with open, nucleotide-free NBDs.
There are two fates of the inward-facing conformation. One route occurs when
the intracellular concentration of L-methionine is high; L-methionine binds to the
C2 domain of MetNI and stabilizes the transporter in the inward-facing state. L-
methionine bound inward-facing MetNI is called the inhibition state. The other fate
is when ATP binds to the transporter and forms ’ET’, which after binding MetQ will
start a new transport cycle.
The Inhibition State
Unique to the MetNI system, L-methionine binds the C2 domain of MetNI and
stabilizes the inward-facing state. This is believed to be the molecular cause for
the phenomenon of trans-inhibition (Kadaba et al., 2008; Yang and Rees, 2015).
The effect of L-methionine binding to the complex was investigated through a
BiaCore experiment with mutant N229A MetQ (mutant contributed by P. Nguyen),
which significantly compromises the capacity of MetQ to bind L-methionine, which
allows us to examine the effect of L-methionine binding the C2 domain. We
immobilized the N229A MetQ on a sensor chip, and a binding curve was generated
when varying concentrations of L-methionine was titrated—each titrant consists a
constant concentration (1 µm) of E166QMetNI solubilized in 0.025%DDM, 25mm
TAPS pH 8.5, 250mm NaCl, 1mm ATP, and 1mm EDTA. The binding curve fit a
1:1 model (Fig. 3.10) and yielded a Kd of 220 µm, compared to 30 µm in a separate
ATPase activity measurement (Yang and Rees, 2015).
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Figure 3.10: Kd for L-methionine binding to the C2 domain of MetNI is
2.2 × 10−4 m. To measure the binding capacity of the C2 domain to L-methionine,
the mutant N229A MetQ was immobilized on the sensor-chip. Varying concen-
trations of L-methionine (100 pm to 16mm) were titrated to the sensor chip. Each
titrant has a constant concentration of the Lm construct of E166Q MetNI (1 µm)
solubilized in 25mm TAPS pH 8.5, 250mm NaCl, 0.025% DDM, 1mm ATP, and
1mm EDTA. The results are plotted with the y-axis as the reported concentration
of MetNI complex; x-axis as [L-methionine]. The binding curve fits to the one to
one binding model and yielded a Kd of 2.2 × 10−4 m. There is an observation of
cooperativity in the fit.
3.3 Discussion
We characterized the kinetics and affinities of themajor transporter conformations of
MetNI during the transport cycle. These conformations are: the pre-translocation,
outward-facing, post-translocation, inward-facing, and inhibition state. Using these
measurements, along with previously reported structural information, we developed
a quantitative transport-framework (Figure 3.11).
According to this model, apo-, unliganded-MetNI readily binds ATP to form ’ET’.
’ET’ is predicted to bind to a closed, liganded MetQ; this interaction results in
the pre-translocation state. The pre-T has an affinity of 1.1 × 10−6 m. When L-
methionine moves to the translocation pathway, the transporter adopts the outward
conformation. We trapped the outward by allowing a complex to be formed between
apoMetQ and ATP-bound E166QMetNI. We believed that the trapped outward had
undergone a conformational change—upon MetNI binding to MetQ—to achieve
a high affinity complex. This two-step reaction is fitted to the two-state model.
The forward and reverse rate constant for complex formation are 5.6 × 103 m−1 s−1
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ETQ ETQ* EDQ ED + Q
Pre-T Outward Post-T Inward
MetQ closed, liganded open open not bound
TMDs inward outward inward inward
NBDs ATP, semi-open ATP, closed ADP-Pi, semi-open free, open
Technique MST MST SPR SPR N/A
Constants Kd Kd k1 k−1 Kd kdissociation N/A
Unit m m m−1 s−1 s−1 m s−1 N/A
Constants 1.1 × 10−6 2.7 × 10−8 5.6 × 103 7.4 × 10−5 1.1 × 10−8 1.1 × 10−2 No Complex
Fig. 3.4 Fig. 3.4 Fig. 3.6 Fig. 3.8 N/A
Table 3.5: A summary of the kinetic constants of different conformations for
MetNI. The major conformations include pre-T, outward, post-T, and inward con-
formation. All of these conformations have been characterized kinetically and
thermodynamically by biophysical techniques i.e. SPR and MST. k1 is and k−1
is for the forward and reserve rate constant for MetNI-MetQ complex formation,
respectively. k2 and k2 is the forward and reverse rate constant for an isomerization
step, respectively. Kd is the dissociation constant for MetNI and MetQ forming
MetNI-MetQ.
and 7.4 × 10−5 s−1, respectively. The forward and reverse rate constant for the
isomerization are 1.7 × 10−3 s−1 and 1.2 × 10−2 s−1, respectively. The Kd is fitted
to be 1.1 × 10−8 m. This affinity similar to the value measured with MST (Kd =
2.7 × 10−8 m; Figure 3.4). The conformational change from pre-T to outward is
concomitant to the substrate dissociates from MetQ, and binds to the translocation
pathway site. Therefore, the outward is in association with an open, unliganded
MetQ. Also, it has closed, ATP-bound NBDs that are ready for hydrolysis.
While the substrate remains in the translocation pathway site, a conformational
change from the outward to the post-T occurs turning the substrate to the cytoplasm as
the two TMDs open up towards the inside of the cell. Hydrolysis occurs concomitant
to substrate translocation. Since hydrolysis stimulates the dissociation of MetQ
from MetNI, the transporter returns to the inward-facing state, which is inactive
for substrate transport and hydrolysis. There are two fates to the inward-facing
intermediate. If the concentration of ATP is high, most of the transporter is ATP-
bound, which means most of the transporters are in the ’ET’ state. Otherwise, if
the L-methionine concentration is high relative to ATP, both L-methionine and ATP
can bind to the transporter. As long as L-methionine is bound to the C2 domain, the
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transporter adopts an inhibition state, which is inactive for transport.
Figure 3.11: Thermodynamics of the MetNI-Q transport cycle. This model
proposes six intermediates during the transport cycle, with four of the six states as
complexes. An additional conformation, EID is included in the trans-inhibition step.
During this step, the intracellular concentration of L-methionine as an inhibitor (I)
is high, I binds to ED to inhibit ATP hydrolysis. The model predicts that EID, the
enzyme-inhibitor complex, will not be released by the addition of substrate, but
instead by the decreased concentration of the inhibitor.
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3.4 Materials and Methods
Cloning, expression, and purification of MetQ
The MetNIQ operon was amplified from Escherichia coli K-12 genomic DNA and
cloned into a zero blunt pCR-4 TOPO vector as described in (Kadaba et al., 2008).
The MetQ gene, lacking the stop codon, was subcloned using oligonucleotides
that included NdeI and XhoI restriction-enzyme sites, and then ligated into the
pET21b(+) vector with a C-terminal 6x-histidine tag. The cloned plasmids were
expressed separately in E. coli BL21 (DE3) gold cells (EMD) at 37 ◦C in Terrific
Broth medium with 100 µgmL−1 ampicillin. The cells were induced at OD600 ∼
4.0 with 0.4mm IPTG for 2 h, then harvested and stored at −80 ◦C.
For purification of matureMetQ, periplasmic extract was prepared by re-suspending
10 g of cell paste in 10 ml of 40% sucrose, 10 mM Tris-HCl pH 7.5, and 1 mM
EDTA, and stirred for one hour at room temperature. The cells were then shocked
by addition of 500 ml of ice-cold water. After stirring for 10 min, buffer components
were added to a final concentration of 25 mM Tris pH 7.5, 150 mM NaCl, and 17
mM imidazole. The resulting suspension was then centrifuged at 37,500 x g for 30
min to remove all cellular debris from the periplasmic extract. MetQ was isolated
from the periplasmic extract by immobilized metal ion affinity chromatography
using a 5 ml Ni-NTA column (GE). The affinity column was washed with 25 mM
Tris pH 7.5, 150 mM NaCl, and 17 mM imidazole for 10 column volumes. Protein
was then eluted from the column using 25 mM Tris pH 7.5, 100 mM NaCl and
150 mM imidazole. Peak fractions were dialyzed against 25 mM Tris pH 7.5 and
150 mM NaCl overnight, and then concentrated to 30 mg/ml using a 10kD MWCO
concentrator (Millipore).
The full-length MetQ protein cloned for this work, including the signal sequence
and the C-terminal 6x-his tag, has the sequence:
MAFKFKTFAAVGALIGSLALVGCGQDEKDPNHIKVGVIVGAEQQVAEVAQ
KVAKDKYGLDVELVTFNDYVLPNEALSKGDIDANAFQHKPYLDQQLKDRG
YKLVAVGNTFVYPIAGYSKKIKSLDELQDGSQVAVPNDPTNLGRSLLLLQKV
GLIKLKDGVGLLPTVLDVVENPKNLKIVELEAPQLPRSLDDAQIALAVINTTY
ASQIGLTPAKDGIFVEDKESPYVNLIVTREDNKDAENVKKFVQAYQSDEVY
EAANKVFNGGAVKGWLEHHHHHH
The cleaved signal sequence is highlighted in bold, so that the purified protein used
in this study consists of residues 17 to 279, of which residues 29-273 (underlined)
are observed in the electron density.
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Unfold and refold MetQ to get rid of co-purified L-methionine
We also learned from the structural studies (Johnson et al., 2012) that MetQ in the
absence of substrate would give the highest affinity. Therefore, the purification of
the MetQ has undergone an unfolded (with high concentration of guanidinium HCl)
and a refolded step to eliminate co-purifying methionine.
Post cell lysis (Section 3.4), supernatant was separated from the cell pellet via ultra-
centrifugation. The supernatant was then loaded onto an affinity chromotagraphy
column. The loaded MetQ goes though washed with the Purification buffer, then
an unfolding step with the Unfolding buffer, another wash step, and then was eluted
with the Elution buffer. Buffer conditions are listed below.
Purification buffer (25mM Tris-HCl pH7.5, 150mM NaCl) and Elution buffer
(25mM Tris-HCl pH7.5, 150mM NaCl, 1M Imidazole). The unfolding buffer
(6 M Guanidine-HCl, 25 mM Tris-HCl pH7.5, 150 mM NaCl, 1mM BMe). The
refolding buffer (25mM Tris-HCl pH7.5 , 150mM NaCl).
Purification of MetNI
Purification of wild-type and mutant E166Q MetNI was carried out as described
(Johnson, Nguyen et al. 2012) with the one modification that buffer containing 20
mM TAPS pH 8.5, 100 mM NaCl and 0.025% DDM (with varying amounts of
imidazole) was used in all purification steps (the original protocol used 250 mM
NaCl and different detergents).
SPR Assay
The Lo construct of MetQ was overexpressed, purified, unfolded and then refolded
using 6 M guanidine hydrochloride. MetQ was then immobilized on a CM5 (car-
boxymethyl dextran) chip (GEHealthcare, BR-1005-30 ) gold surface via EDC-NHS
activated carboxylate groups. 1 µg/mL ofMetQwas concentrated to the surface with
pH 4.5 acetate (the p.I. of MetQ is 5.63 (ExPASy Estimate)) to achieve a signal of
100 RU. Excess MetQ on the surface was washed off using a 50 mMNaOH solution.
The carboxyl groups on the sensor-chip are activated to provide the reactive succin-
imide esters with the addition of a mixture of NHS (N-hydroxysulfosuccinimide)
and EDC (1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride). The
primary amine groups on MetQ can bind to these active esters readily to form an
amide bond. Upon binding of MetQ to the dextrin, the unbound reactive groups on
the surface were deactivated with the addition of ethanolamine. The running buffer
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for immobilization is HBS-EP+.
BtuF, the binding protein for the Vitamin B12 transport system was immobilized
in the control cell. BtuF has a similar mass to MetQ and BtuF is also an ABC
transporter binding protein. Therefore, it makes it a good choice for a control. The
use of BtuF is to preclude any non-specific binding to the chip or other random
proteins. MetNI was introduced into the microfluidic system by suction. The
addition of MetNI to MetQ is speed-controlled and the signal over time of start
injection to the end is recorded. The sensor-chip is equilibrated and normalized
before the first injection of the MetNI, and subsequently takes real-time pre-steady
state measurement of MetNI binding to MetQ. The refraction index change when
matter is introduced to the system is subtracted from the binding curve. The curve
is also normalized with respect to the control flow cell.
In theory, either MetNI or MetQ can be the ligand (to be immobilized on the sensor
chip). However, there has been no success immobilizing MetNI, either is via amine
chemistry, Antibody capture, or Ni-NTA capture. With the former two, there is no
binding response. With the latter, there is constant a decrease of the signal meaning
the ligand keeps falling off of the NTA tethering.
The only successful immobilization is through a EDC/NHS target towards primary
amines in MetQ. MetNI serves as the analyte. Although this immobilization config-
uration is non-specific, measurement is consistent and reproducible each time. It is
predicted some primary amines aremore exposed than others and the immobilization
ended up specific.
The MetQ-immobilized sensor-chip was then equilibrated with the assay running
buffer (25 mM TAPS, pH 8.5, 250 mM NaCl, 0.025% DDM, 1 mM ATP, 1 mM
EDTA). E166Q MetNI (Lm construct) of varying concentrations (range from 1
to 1000 nM) was injected to interact with MetQ in a time-, and speed-controlled
manner. After each injection, a glycine solution of pH 2.0 was used to wash off the
bound E166Q MetNI. MetQ was tested to be stable under this washing condition.
For MetNI titration against, MetQ-ATP, varying concentrations (ranging from 16.5
nM to 1000 nM) of E166Q MetNI were added (one concentration per cycle). The
binding curves were fitted (See Figure SPR.1) to a 1:1 model that describes one
analyte binds to one ligand. k1 of 1600 M−1s−1 and k−1 of 9.95 ×10−5s−1 were
obtained.
For ATP titration against MetNIQ, a constant concentration (1024 nM) of E166Q
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MetNI (20 mM, TAPS, pH 8.5, 250 mM NaCl, 0.025% DDM, 1 mM EDTA) was
titrating against different concentrations (1mM, 300 210 µm, 50 210 µm, 20 210 µm)
of ATP (Figure. SPR.2). The R+max is plotted against the concentration of ATP
and a Kd of 50 210 µm is obtained.
ATP Titration on E166Q MetNI and both MetQ (N229A and wild-type) 50 nM
wild-type MetQ (Lf construct) was labeled with Cy3 with 40% labeling efficiency
and 1 210 µm of E166QMetNI, were titrated against varying concentrations of ATP
(ranging from 0.5 210 µm to 512 210 µm). An EC50 of 25.1 ± 0.525 µM and a hill
coefficient of 1.6 ± 0.0335 210 µm was obtained. If n is fixed to 2, an EC50 of 24.4
± 0.595 was obtained.
Data Analysis
Data analysis started with establishing the model of the molecular interaction. Com-
mon models include 1:1; two-state, bivalent, etc. The prediction of which model
would fit the data best can be derived from the prior experimental data. Here we
describe the derivation of a 1 : 1 model. More complex models can be derived
following the same procedure.
The 1:1 model, which describes one molecule, A binds to one molecule, B to form
complex AB. Because of available biophysical data on ABC type I transporters, we
are confident that this model is accurate in that one MetQ binds to one MetNI.
The method to deduce the rate of ATP hydrolysis will be discussed. The rate of
ATP hydrolysis was assumed to indirectly correlate to the rate of dissociation. In
the case of dissociation being the limited rate, then the measured rate is still the rate
of dissociation.
Rmax is the analyte binding capacity of the surface (RU). It is obtained by fitting
binding data to a model. Below we show derivation for a 1:1 binding model
according to Equation 3.4.
A =MetQ
B =MetNI
A + B = AB (3.4)
These are the relationships that are true:
[A]max ≈ Rmax (3.5)
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[B] is constant
[A] = [A]max − [AB] (3.6)
[AB] ≈ R (3.7)
Kd =
k−1
k1
(3.8)
d[AB]
dt
= k1[A][B] − k−1[AB] (3.9)
d[R]
dt
= k1(Rmax − [AB])[B] − k−1[AB] (3.10)
d[R]
dt
= k1(Rmax − R)[B] − k−1R (3.11)
Solve the differential equation for R:
R =
Rmax[B]
Kd + [B] (1 −
1
exp(k1[B] + k−1)t
) (3.12)
Aggregate the constants together for fewer constant terms:
R = C1(1 − exp(−C2t)) (3.13)
Using Eq. 3.13 to fit the SPR binding data. The fit will output C1 and C2. The
goodness of the fit can be evaluated using graphing the residuals between the data
and the fit as well as chi square.
C1 =
Rmax[B]
Kd + [B] (3.14)
C2 = k1[B] + k−1 (3.15)
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The same approach is taken to established relationship between kinetic constants
with concentration of binding partners the Two State model (Equation 3.17). The
equation for the two State reaction is:
A + B = AB = AB* (3.16)
k1 is the association rate constant for analyte binding, in the unit of(M−1s−1).
k−1 is the dissociation rate constant for analyte from the complex, in the unit of s−1.
k2 is the forward rate constant for the conformational change, in unit of s−1.
k−2 is the reverse rate constant for the conformational change, in unit of s−1.
All four parameters are obtained from fitting the binding data to the Two Model
state.
Kd =
k−1
k1
× k−2
k−2 + k2
(3.17)
Sometimes it is possible to deduce other information than kinetics of molecular
binding. An example of this would be the rate of ATP hydrolysis. Once a ATPase
defective mutant of the MetNI transporter in the presence of EDTA; separately
with Mg2+. In comparison, one can calculate the rate of stimulated hydrolysis by
magnesium.
MST Assay
The E. coliMetQ sequence contains one cysteine residue at amino acid position 23.
Purified wild-type MetQ and N229A MetQ were labeled with Cy3-maleimide (GE
Healthcare), according to the manufacturer’s instructions, in buffer containing 25
mM Tris pH 7.5, 150 mM NaCl, and 10 mM TCEP pH 7.5. Unreacted dye was
removed using a Superdex 200 10/300 GL column (GE Healthcare) equilibrated
with the aforementioned buffer condition. The label to protein ratio was determined
using a NanoDrop 2000 Spectrophotometer (Thermo Scientific) at 550 and 280 nm,
and a labeling efficiency of 10% was calculated. Fluorescence measurements were
performed on a Monolith NT.115 Instrument (NanoTemper Technologies GmbH) at
25 °C using standard capillaries. Varying concentrations (ranging from 1.95 nM to
32 µM) of unlabeled E166QMetNI in ATP buffer (1 mMATP, 1 mMEDTA, 20mM
TAPS pH 8.5, 100 mM NaCl, and 0.3 % Cymal-5) were titrated against a constant
concentration of MetQ (101 nM of wild-type MetQ or 99 nM of N229A MetQ).
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Fluorescent intensity as a function of E166Q MetNI concentration was normalized
to fraction bound by averaging the intensity values for the lowest three concentrations
of E166Q MetNI per experiment. This background intensity was subtracted from
all concentrations to yield corrected intensity values. The corrected intensity values
were then divided by the corrected intensity at the highest concentration of E166Q
MetNI to normalize intensity values to fraction bound values. Dissociation constants
for wild-typeMetQ or N229AMetQ binding to E166QMetNI were calculated using
the Kd Fit function of the NanoTemper Analysis 1.5.41 software. Three independent
MSTmeasurements per condition were conducted, and error bars represent standard
error of the mean.
Substrate Binding Sites Measurement
A calibration curve was generated by titrating varying concentrations of E166Q
MetNI solubilized in 1 mM ATP containing buffer (25 mM TAPS, pH 8.5, 250mm
NaCl, 0.025% DDM, 1 mM ATP, 1 mM EDTA). Upon calibration, using the same
buffer. MetQ was immobilized via a covalent bond to carboxymethylated dextran
CM5 sensor-chip within the microfluidic channels for the Biacore system while
MetNI was flowing through the volume in the channels. Since L-methionine has an
inhibitory effect on the stability of the complexMetNI-MetQ, as L-methionine binds
to each binding site on the complex, more complex is destabilized and this change
can be detected by SPR. To do this measurement, both proteins MetNI andMetQ are
kept at a constant concentration, the concentration of L-methionine varies. Binding
information of L-methionine can be extrapolated depending on the cooperativity of
the binding sites.
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3.5 Supplemental Materials
Evaluation methods for SPR binding data fitting
The SPR binding curves are fitting based on different models that are appropriate
for the different reactions. How good are the fits? Primarily, we have two ways of
evaluating the fits: the residual graph and the Chi-squared test.
The residual graph
The residual of a fitted binding curve is described by Equation 3.18. For example,
we plotted out the residual for an experiment in Chapter 3 (Figure 3.6). As seen in
Figure 3.12, we can see that the highest concentration of MetNI (the blue curve) fits
the least. The fit becomes better gradually as the protein concentration decreases.
This tread might be due to the artefacts that arise when the protein concentration is
too high.
residual = data − f it (3.18)
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Figure 3.12: Residual analysis for the fit for the data from the SPR experiment with
ATP and EDTA.
The residuals show that the fit was better for titration of lower MetNI concentration
as the residuals decrease towards the end of the table. This is consistent with the
visual inspection of Fig. 3.6. The residual for k−1 are very small and the same. It
reflects the almost identical dissociation curves.
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Residuals - 8192 nm 4096 nm 2048 nm 1024 nm 512 nm 256 nm 128 nm 64 nm 32 nm
for k1 103 4.7 4.1 2.1 3.4 2.8 2.2 1.6 1.2 0.8
for k−1 10−4 1 1 1 1 1 1 1 1 1
Table 3.6: Residuals for the data and the fit as a metric to evaluate the quality of the
fit. Calculation was done with MATLAB.
[MetNI] 8192 nm 4096 nm 2048 nm 1024 nm 512 nm 256 nm 128 nm 64 nm 32 nm
chi2 0.02 0.02 0.028 0.03 0.039 0.048 0.06 0.079 0.1
Table 3.7: Chi square calculation for the data fitting.
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C h a p t e r 4
CONCLUSION
The framework for understanding conformational changes coupled to substrate
translocation for ABC transporters started with the Alternating Access Model in
1966. Through four decades of structural determination of ABC transporters, there
have been four significant conformations (pre-translocation, Outward-facing, post-
translocation, and inward-facing) identified to be pivotal for transport. My interest
has been to characterize the E. coli MetNI methionine ABC transporter that was
first identified in the 1970s.
We placed an emphasis on kinetic and equilibrium measurements and a focus on
understanding conformational changes of the transporter during the transport cycle
to complement pre-existing structural knowledge. We quantified the nature of the
different conformations for the MetNI system. We also characterized the binding
affinity of the substrate binding sites. We added rate and affinity information for
each major conformation to the proposed kinetic transport scheme.
Collating the biophysical measurements made in detergent and comparing to other
ABC transporter studies, the overall data support a transport mechanism where the
binding protein first binds to its substrate in the periplasm to increase the local
substrate concentration. The liganded binding protein then associates with the
membrane transporter, forming the pre-T state. The opening of the binding protein
upon complex formation allows the substrate to be dissociated from the binding
protein and to bind to the translocation pathway site of the transporter—this is the
outward state. ATP binding and hydrolysis provides energy for the conformational
change of the TMDs from outward- to inward-facing and expose the substrate to
the cytoplasm. This post hydrolysis ADP- and Pi-bound transporter is the post-T
state. There are diverse mechanisms for regulatory inhibition. For MetNI, substrate
binding the C-terminal of MetN is believed to stabilize the transporter in its inward-
facing conformation, which is a state not poised for either substrate translocation or
ATP hydrolysis.
This model describes the MetNI kinetic mechanism. It is predicted that we may
borrow knowledge from it to study other members of the ABC Type I transporters.
Future challenges include obtaining parallel biophysical measurements of the dif-
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ferent conformations in lipid environments to discern artifacts arising from the use
of detergents to solubilize MetNI from the membrane bilayer. An important com-
ponent of the future work includes the establishment of a transport assay setup.
There are four main components to understanding the transport cycle: structures
of intermediate states, kinetics, ATPase activity, and transport activity. While we
have some knowledge on the first three, transport activity of MetNI remains the last
major component to be studied.
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C h a p t e r 5
APPENDIX
SPR and MST
For inter-molecular binding interaction, which Instrument to try first?
Supposedly the goal is to obtain kinetic and equilibrium properties of an ABC
transporter, which technique would you try first? Here we discuss the financial-
and time- costs for an experiment for each of the instruments to offer insights and
recommendations for starting an experiment. It is recommended one does not start
with SPR because first, the gold plated sensor chip is running between $200 to $600
each. Second, the current generation of SPR still requires an extensive amount of
time to clean the sensor chip, perform immobilization, and do binding experiment.
Besides the time and cost demand, one has pay utmost care when operating SPR.
This applies specifically to the docking of a chip that had been used and has been
stored in a buffer. The chip has to be cleaned and dried before docking. The cleaning
techniques is intricate. We have observed several times when this step was not well
practiced, the flow cell was damaged and each flow cell costs about $7000.
ITC can be attempted if there is some knowledge of the what range the affinity falls
in. If the expected affinity is in the high nM and low uM, it is feasible to start with
ITC. Since the output signal depends entirely on the heat exchange of the binding
reaction, it is possible that such heat exchange is so minimal that it is not detectable
by ITC, hence the false negatives.
Perturbations
SPR requires immobilization of one of the binding partner to a sensor chip. Such
treatment is considered a perturbation to the system. The immobilization must
not obscure the binding site. However, in practice, it is difficult to prevent this;
hence the false negative can often occur. For example, there is strong evidence that
MetNI binds to MetQ in the presence of ATP and EDTA. However, with several
immobilization methods (Ni-NTA immobilizing MetNI or antibody immobilization
MetNI) do not give positive binding reading. In fact, with the Ni-NTA method,
binding was observed initially, then dissocation occurs quickly even though the
concentration of the analyte is constant. This is an indication that Ni-NTA does not
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hold onto MetNI tightly to enable it to interact with MetQ in a stable platform. This
makes sense as Ni-NTA does not form a covalent bond with MetNI. Explorations
are needed to find the right immobilization configuration. False positive, which
is immobilization that causes enhancements of the binding activity, can arise from
immobilization but is less common.
The perturbation or MST is a fluorescence label of one of the binding partner. False
positives arise much more frequent than SPR. Also most of the proteins labeling is
not specific. Current labeling methods include the labeling of cysteine or lysine.
Given how abundant lysine is, label for an MST measurement is often non-specific.
For example, we tried labeling MetNI with both lysine and cysteine chemistry.
Unfortunately, no binding responses were reported. The reasons can be that the
labeling obscures the binding site for MetQ. The labeling of MetQ with cysteine
was successful, however. There is only one cysteine in MetQ. Labeling MetQ is a
specific addition of a fluorephore.
There is no perturbation of ITC. The response arise from the heat exchange from the
binding reaction. If the binding of the two molecules is exothermic, heat is released.
If it is endothermic, heat is absorbed. These are intrinsic properties of each binding
reaction, and therefore requires no external treatment to enable measurement. In
this respect, ITC is superior to the other two techniques.
Detection Range
What determines the detection range is limited by the physical theorems that the
instrument is based on. For instance, for SPR, it is limited by the smallest mass
that can change the refraction index of the sensor-chip surface as the change of
refractive index is the output of the instrument. For instance, SPR cannot detect a
small molecule like L-methionine. SPR can detect from low nM to uM. It is not
sensitive to low affinity, in the mM range.
MSThave different versions of detection range. TheNT. pico is specifically designed
for detecting high affinities, often for antibody interaction. The NT.115 is designed
to detect from nM to mM. Our observations and comments are specifically for NT.
115 as this is the instrument we used for all the studies reported.
ITC has the capacity to detect nM to mM. However, in practice, very high affinity
can be difficult to quantify because it might require so small protein concentration
as a titration step that it would be close to impossible to do. Low affinity requires
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a very large amount of proteins for measurement. Given that ABC transporters are
membrane proteins, whose solubility depends on either detergent or proteolypo-
some, such high concentration of detergent solubilized protein might compromise
its activity and stability.
There had been significant difficulties to characterizing the binding sites that pertains
to the limits of the biophysical techniques that are available to study this system.
The main techniques that have been explored are SPR, MST, and ITC. With SPR,
the lower detectable limit is much bigger than the mass of L-methionine, which
is 150 Dalton. Therefore, SPR cannot be used to directly to measure affinities of
the L-methionine binding sites. A different technique, based on the phenomenon,
MicroScale Thermophoresis (MST), allows for steady state measurement of binding
interactions. However, while protein-protein interactions have been characterized
successfully with this technique, protein-small molecule interactions are difficult to
measure, probably due to the smaller change of conformation change and hydration
shell upon binding yielding a small, close to background change in signal.
An indirect SPR assay has been developed to address this technical challenge. MetQ
was immobilized via a covalent bond to carboxymethylated dextranCM5 sensor-chip
within the microfluidic channels for the Biacore system while MetNI was flowing
through the volume in the channels. Since L-methionine has an inhibitory effect on
the stability of the complex MetNI-MetQ, as L-methionine binds to each binding
site on the complex, more complex is destabilized and this change can be detected
by SPR. To do this measurement, both proteins MetNI and MetQ are kept a constant
concentration, the concentration of L-methionine varies. Binding information of
L-methionine can be extrapolated depending on the cooperativity of the binding
sites. Here we discuss how the different binding sites were identified, and how the
binding affinity for each site was quantified.
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